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SUMMARY
Synthetic routes from thebaine to l4s-acylaminodeoxydihydro-
codeinones were explored. Each route was eventually frustrated by
our inability to remove reductively either a 4-phenoxy or a 4-(1-phenyl-
tetrazol-5-yl)oxy group from a number of derivatives.
Routes to the preparation of a thebaine derivative containing
a piperidine nitrogen-carbon(14) bridge were investigated. In the
N-northebaine series no bridged compounds were formed but in the
thebaine series two quaternary ammonium chlorides with the desired
bridge were prepared.
Treatment of the cycloadduct 6S,14S-(N-chloroacetylepoxyimino)-
6,14-dihydro-N-t-butoxycarbonylnorthebaine with sodium ethoxide in
ethanol afforded, unexpectedly, l4S-(2,2-diethoxyethanoylamino)-N-t-
butoxycarbonylnorcodeinone. Similarly, the cycloadduct 6S,14S-
(N-phenylacetylepoxyimino)-6,14-dihydrothebaine was found to react with
high stereoselectivity with methoxide to give l4S-[(S)-2-methoxy-2-
phenylethanoylamino]codeinone. Treatment of the hydroxamic acid
l4e-(N-2-phenylethanoylhydroxyamino)codeinone with toluene-p-sulphonyl
chloride in pyridine followed by methoxide gave a yellow product which
had incorporated one molecule of pyridine. All the foregoing reactions
are believed to proceed via aziridinone (a-lactam) intermediates.
Further studies on model compounds supported the proposed mechanisms.
An alternative, high yielding synthesis of the known a-lactam, l-t-butyl-
3-phenylaziridin-2-one, has been achieved by treating the appropriate
hydroxamic acid with trifluoromethanesulphonic anhydride and triethyl-
amine at 700 C .
The reaction of the hydroxamic acid l4S-(N-chloroacetylhydroxy-
amino)-N-t-butoxycarbonylnorcodeinone ethylene acetal with ethoxide
gave the l4S-aminonorcodeinone derivative. A similar treatment of
iii
the corresponding hydroxamic acid derived from thebaine and also of
model compounds yielded ester products. These reactions are
rationalised in terms of oxazetidinone intermediates.
iv
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CHAPTER 1
INTRODUCTION
'~nd Helen, daughter of Zeus, poured into the wine they were
drinking a drug nepenthes whiah gave forgetfulness of evil."
Homer in The Odyssey.
For centuries, nepenthes and other preparations of opium, the
dried latex of the poppy plant Papaver somniferum, have been used to
alleviate pain and produce euphoria. The principal active constituent
morphine (1; R = RI = H) was first isolated by Serturner1 in 1805 and
its structure was established 120 years later by Gul1and and Robinson.2
In the intervening period various minor alkaloids were discovered, of
which codeine (1; R = Me, RI = H) a well-known cough remedy, and
thebaine (2) a non-narcotic and strychnine-like poison, bear particularly
strong resemblance to morphine. In 1956 Gates and Tschudi3 reported
the first total synthesis of morphine thereby providing confirmatory
proof of its structure.
2
(1 ) (2)
2Due to side reactions, viz. spastic constipation, depression of
the respiratory centre, sedation, euphoria and addiction, morphine is
not the ideal analgesic. In the search for a potent analgesic with no
adverse effects, chemists have made modifications to the morphine nucleus
and synthesised new types of skeleton. The synthetic compounds have
nuclei akin to that of morphine, viz. 4-pheny1piperidines (3),
morphinans (4) and 6,7-benzomorphans (5), with side chains whose nature
and location were suggested by results in the morphine field. For example
pethidine (3; R = Me), 1evorphano1 (4; R = Me) and metazocine (5; R = Me)
are all analgesics but have similar disadvantages to morphine.4
HO
HO
R R
Me
(3) (4) (5)
Before the detailed structures of the morphine alkaloids were
known, minor modifications had already yielded derivatives with increased
activity. The most notable of these was heroin (1; R = RI = Ac), and
in 1898, on the basis of pharmacological reports, it was marketed
(misleadingly!) in Germany as a non-addictive analgesic. More recently,
morphine derivatives with a hydroxy or amino group at the 14-position
have been prepared and some of these show analgesic activity in excess
of that of morphine.s,s
N-A11y1normorphine (6), rediscovered more than 25 years after its
original preparation by Poh1 in 1915,7 was recognised as the first
3of the antagonists, a group of compounds which later included lV-propyl
and /I-cyclopropyl methyl der; vat; ves. A pure antaqont st produces none
of the pharmacological actions characteristic of morphine but can block
the effects of it and other agonists. Naloxone (7) and nalorphine (6)
are two such examples and are used as antidotes in cases of narcotic
overdose.
(6 ) (7)
Generally most antagonists, for example pentazocine (5; R = CH2CH=CMe2)
and cyclazocine (5; R = cyclopropylmethyl), have a degree of agonist
activity, i.e. they are partial agonists, and since they are less open
to abuse they make clinically valuable analgesics.
A novel series of potent agonists were discovered by Bentley et at.S
in the following way. The conjugated diene system of thebaine reacted
with a,e-unsaturated ketones to give high yields of Diels-Alder adducts
with the general structure (8; R = alkyl).
Mea
NMe (8)
Mea \\
ca~'R
4Although, in principle, a number of adducts are possible, only the
isomer with the stereochemistry shown was formed. This outcome
resulted from dienophile addition occurring readily only to the
exposed S face of the diene, and under electronic control due to the
14-position of thebaine being electron rich. Several of the adducts
were found to be more potent analgesics than morphine.
Treatment of the ketones with Grignard reagents gave the related
series of tertiary alcohols (9; R,RI = alkyl). A high degree of
Mea" ,
NMe
Mea
(la)
(9 )
stereoselectivity was observed in these reactions due to the reagent
participating in a six-membered cyclic intermediate (10) in which
attack on the carbonyl group from above is less hindered than attack
from below. The most extensive series of alcohols studied was that
obtainable from the ketone (8; R = Me). Structure-activity relation-
sh+ps ? have shown in this series, i.,«, (9; R = Me, RI = alkyl), as the
length of. the hydrophobic group RI increased to a size equivalent to a
three to five carbon chain, potency increased. Peak activity
(500 x morphine) was attained in the phenethy1 derivative (9; R = Me,
5RI = CH2CH2Ph) and further lengthening of the chain resulted in a
steady decrease in activity. Further, demethylation of the C-3
methoxy group of these alcohols yielded a series of very highly
potent analgesics (cf, morphine and codeine). For example, the
phenol etorphine (11; R = Pri) has analgesic activity 12,000 times
HO
MeO' ,\
(11 ) (12)
that of morphine and is widely used for the immobilization of wild
animals for game conservation and veterinary purposes. As mentioned
on p. 3, substitution of the N-methy1 group of morphine by, inter
alia, N-cyclopropy1methy1 produced antagonists. Incorporation of this
feature into the alcohols yielded mixed agonists-antagonists, for
example, buprenorphine (12). Although reduction of the 7,B-doub1e bond
marginally increased the potency, more importantly, it conferred
greater stability on the derivative. Prior to this modification the
alcohols had been sensitive to dehydration and rearrangement to (13)
in acidic media.
6NMe
(13)
~,B-Unsaturated ketones are not the only dienophiles to undergo
Diels-Alder reactions with thebaine; hydroxamic acids (RCONHOH) when
oxidised in situ give short-lived nitrosocarbony1 compounds (RCONO)
whi ch behave 1ikewi se. Nitrosocarbonyl compounds were first
postulated as transient intermediates in the pyrolysis of a mixture
of nitrite esters and a1dehydes10 and in the oxidative cleavage of
hydroxamic acids11 but the isolated products all involved cleavage of
the CO-N bond. However in the presence of conjugated diene systems
such as thebaine, intact nitrosocarbonyl compounds were trapped as the
Diels-Alder adducts (14; R = a1ky1).12,13,14
(14)
7The stereochemistry of the cycloadducts was reasoned to be as
illustrated by analogy with the Bentley compounds and verified in
subsequent reactions. Thus, with the 14-position of thebaine being
electron rich and the nitrosocarbony1 compound being slightly electron
deficient on the nitrogen atom due to the electron withdrawing effect
of the neighbouring oxygen and carbonyl groups, dienophi1e addition
to the exposed B face of the diene afforded the adduct (14) and not
the isomeric species (15).
MeD
MeD' \ \
(15 )
Treatment of the cyc10adducts with anhydrous hydrogen chloride in
ethylene glycol afforded the ethylene aceta1s (16; R = alkyl) in quantitative
yield. These compounds gave a positive reaction with ferric chloride
solution, the qualitative test for hydroxamic acids. Thus, the
presence of a hydroxamic acid group at the 14-position in these
derivatives proved the original structure of the cycloadducts. In
basic solution, if not protected as aceta1s, the hydroxamic acids
rearrange to the pheno 1s (17).
8(16) (17)
The reduction of the hydroxamic acids to the corresponding
amides (18; R = alkyl) has been extensively investigated by
R. I. Gour1ay14 who concluded that the most successful reagent for
the conversion was sulphur dioxide in pyridine. These conditions are
also used for the reduction of aromatic N-oxides.1S Finally, hydrolysis
of the ethylene aceta1s afforded the 14-acy1aminocodeinones (19;
R = alkyl) in ca. 60% yield from thebaine.
(18) (19)
Compounds of this series, i.e. (19; R = alkyl), originally
prepared from l4-nitrocodeinone dimethyl acetal ,16.17 like the Bentley
compounds, show high analgesic potency with suitable hydrophobic side
chains. For example, the 3-phenylpropanoyl derivative (19; R = CH2CH2Ph)
9has analgesic activity 125 times that of morphine.
Opiates act on the central nervous system through receptor sites
on the surface of nerve membranes in the brain and spinal chord .. The
mechanism of action is not clear but it is believed that agonists and
antagonists stereospecifically bind to different, interconvertible,
forms of the receptor. Pure antagonists, which have no intrinsic
agonist activity, can thus prevent attachment and response of the
agonist. Moreover, molecules able to bind strongly to the receptor
and which possess high lipid solubility are the most potent drugs.
The existence of opiate receptors suggested that there may be
naturally occurring, morphine-like substances. In 1975 Hughes and
Kosterlitz19 isolated, from homogenised pig brain, methionine-
enkephalin (20) and leucine-enkephalin (21) in the ratio, 3:1.
H-Tyr-Gly-Gly-Phe-Met-OH
(20)
H-Tyr-Gly-Gly-Phe-Leu-OH
(21)
These peptides behaved like morphine in tests with isolated tissue
preparations and their effects were reversed by antagonists like
naloxone.
The structural relationship between methionine-enkephalin and
the potent 6,14-bridged phenol (11; R = CH2CH2Ph) is not immediately
apparent. However, the enkepha1in may be folded (at least in models)
so that the tyrosyl end group corresponds to the phenol ring and
nitrogen atom of the morphine nucleus, and the phenyl group of the
phenylalanine residue corresponds to the hydrophobic group R. It
is assumed that the enkepha1ins adopt this type of conformation when
bound to the receptor.
The enkepha1ins are rapidly hydrolysed in organisms and are
10
themselves not effective drugs. However, a large number of more
stable analogues have been reported with analgesic activity in
excess of that of morphine.20,21
11
CHAPTER 2
ATTEMPTED ROUTES TO 14-ACYLAMINODEOXYDIHYDROCODEINONES
As mentioned in the introduction, compounds based on the
morphinan ring system (4), particularly those with a 3-hydroxyl group,
are useful analgesics. Thus, removal of the ether bridge between
C-4 and C-5 in thebaine to form deoxY-B-dihydrothebaine (22) is of
considerable interest. The total synthesis of this compound has not
been reported, but its analogue (23) has been prepared22 in 14 steps and
in < 1% yield from 7-methoxy-2-tetralone (24). Further, modification
MeO MeD
MeD
(22) (23) (24)
of the lower ring by Die1s-Alder addition of dienophi1es may lead to
more stable and/or more active analgesics. The original aim of this
project was to form the aforesaid deoxy-6-dihydrothebaine (22),
prepare a series of 14-acy1aminodeoxydihydrocodeinones (25; R = alkyl
or aralkyl) and to compare their analgesic activity with the
corresponding codeinone derivatives.
12
(25)
2.1 By Reduction of a 4-0-Phenyl Ether
Bentley et a~.23 discovered that Birch reduction of thebaine
efficiently cleaved the ether bridge and the product dihydrothebaine-~
(26) was isolated in high yield. The isomeric diene, B-dihydrothebaine
(27), has until recently, only been available through an unsatisfactory
NMe
(26) (27)
lithium aluminium hydride reduction of thebaine.24 The new preparation
of this diene, reported by Razdan et a~.,25 involved carrying out the
Birch reduction of thebaine in the presence of potassamide. Potassamide
conjugated the diene system of (26) to (27) and similar reaction
13
conditions to these have been 'employed by Birch26 to promote conjugation
in simpler methoxydienes. Although an equilibrium 1:1 mixture of the
isomeric dienes (26) and (27) was isolated, fractional crystallisation
afforded pure S-dihydrothebaine (27) in 34% yield. Razdan also
reported that in the presence of sodamide the reduction yielded only
dihydrothebaine-~ (26). However, R. I. Gourlay14 found that sodamide
was an effective conjugation reagent, and also that slightly enriched
mixtures of (27) were obtained by equilibrating the reduction products
with base for several hours.
Further, removal of the hydroxy group in dihydrothebaine-~,
leading to deoxydihydrothebaine-~ (28) was accomplished in two steps
by Sawa et aL.27 By a similar process these workers have also
successfully eliminated the 4-hydroxy group on the alkaloid sinomenine
(29) and some of its derivatives.28 The phenol (26) was converted
into its phenyl ether (30) by an Ullmann reaction with bromobenzene
Mea
Mea
(28)
O~
(29)
~o
NMe
~o
(30)
14
in pyridine in the presence of potassium carbonate and copper. Sodium
in liquid ammonia reduction of this phenyl ether gave the desired
deoxy compound (28) in high yield.
The proposed route to deoxy-B-dihydrothebaine (22) (Scheme I)
was analogous to that used for the preparation of deoxydihydrothebaine-~
(28) .
Mea Mea
HO PhBr Pha
NMe
Mea Mea
(27) ( 31 )
1 Na, NH 3
Mea
NMe
Mea
(22)
SCHEME I
B-Dihydrothebaine (27) was prepared by the method of Gourlay
(see earlier) and, after fractional crystallisation, was 80% pure, the
impurity being dihydrothebaine-~ (26). Treatment with bromobenzene in
an Ullmann reaction converted the phenol to the 4-phenyl ether and
15
the product (31) was isolated after alumina chromatography as a
dark viscous oil. The n.m.r. spectrum of this ether indicated that
a small amount of the isomeric compound (30) was present.
Birch and Dastur29 have observed that catalytic amounts of,
inter aZia, dichloroma1eic anhydride conjugate 1-methoxycyclohexa-
1,4-dienes to their 1,3-isomers. Thus, in an alternative approach
to the desired ether (31), the unconjugated ether (30) was refluxed
with dichloromaleic anhydride, prepared by the method of Forsch and
Roedig30 in toluene and xylene. In each case only starting material
was isolated.
Attempts at sodium in liquid ammonia cleavage of the phenoxy
group on compound (31) yielded a complex mixture of products. While
this work was in progress, Razdan et aZ.31 published a communication
describing the results of a related study. Reaction of the unconjugated
ether (3D) with potassamide in liquid ammonia afforded the benzyl-
isoquinoline (32). Possibly, a similar type of cleavage was causing
the problems encountered in our reduction.
~o
PhD
MeD
(3D) (32)
With this unexpected failure, an alternative route to the
synthesis of deoxY-B-dihydrothebaine was considered, namely, isomerisation
of deoxydihydrothebaine-~. Two sets of conditions were applied, sodamide
16
in liquid ammonia and dich1oroma1eic anhydride in toluene. This
latter reaction, as expected (see above), gave starting material. The
sodamide experiments did not give reproducible results, but in the more
promising cases the n.m.r. spectrum of the reaction products showed
that all the starting material had reacted, and the appearance of two
doublets at 0.4.27 (7-H?) and 06.32 (8-H?) suggested that isomerisation
may have taken place. In the hope that a crystalline adduct could be
formed and isolated these reaction mixtures were treated with nitroso-
carbony1benzene, generated from benzohydroxamic acid and periodate, in
an attempted Die1s-A1der reaction. Further complex mixtures ensued
which were not investigated further.
Owing to the unavailability of deoxy-s-dihydrothebaine it was
decided to leave the phenoxy group on C-4 until a later stage when
further attempts at removal would be made. The revised route to the
l4-aminodeoxydihydrocodeinones now envisaged is outlined in Scheme II.
Since the diene system of a-dihydrothebaine phenyl ether (31) is
essentially the same as that of thebaine it too should undergo Diels-
Alder reaction with nitrosocarbonyl compounds. Accordingly, dihydro-
cinnamohydroxamic acid was oxidised with sodium periodate in the
presence of (31) and the expected cyc10adduct (33; R = CHzCHzPh) was
isolated in 47% yield. The above hydroxamic acid was chosen to
establish the feasibility of the route since in the 14-acylamino-
codeinone series the 3-pheny1propanoy1 derivative was the most active
analgesic. 8y analogy with the thebaine adducts (see introduction)
and on the basis of later experiments (see below), the cycloadduct was
reasoned to have the structure shown.
The adduct was treated with anhydrous hydrogen chloride in ethylene
glycol to afford a 1:1 mixture of the protected (34; R = CH2CH2Ph) and
unprotected (36) (see later) forms of the thebainone. 80th of these
17
MeD
RCDNHDH PhD
NMe NaID4 NMe
,
MeD MeD"
(31 )
(33)
1 HOCH,CH,OH. H+
MeD MeD
PhD S02' PhD
pyridine
(35 )
1 LiAlH,
(34)
1. Na, NH3
+
NMe 2. H
SCHEME II
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derivatives gave a positive reaction with ferric chloride, i.e. they
were hydroxamic acids, and hence the structure of the cycloadduct was
establishedM Fortunately, the unprotected thebainone, utilized in
later reactions (Scheme III), proved insoluble in the common solvents,
unlike its ethylene acetal, and so separation was readily achieved.
Sulphur dioxide in pyridine reduced the hydroxamic acid (34; R = CH CH Ph)
to the corresponding amide (35; R = CH2CH2Ph), but neither of these
compounds was obtained crystalline.
The next step proposed involved lithium aluminium hydride
reduction of the amide carbonyl group in (35; R = CH2CH2Ph). The
i .r. spectrum of the reaction product after workup showed a significant
adsorption at 1 670 cm-I, identical to that in the starting material.
As repetition yielded similar results no further work related to
Scheme II was carried out.
A parallel series of experiments (Scheme III) leading to the
thebainone (37) was also successfully implemented. Thus the cyclo-
aqduct (33; R = CH2CH2Ph) was hydrolysed to the hydroxamic acid
[(36), af. p. 16] which was reduced as before to the amide (37). A
sample of this amide was tested for pharmacological activity but it
was found to be inactive, probably due to the presence of the phenoxy
group at C-4.
19
PhO
MeO
MeO
(36)
1 502• pyridine
~O
PhO
(37)
SCHEME III
2.2 By Reduction of a 4-O-{1-Phenyltetrazol-5-yl) Ether
Beyerman et aZ. have observed that the phenolic hydroxy group
at C-2 in the synthetic morphinans (38; R = OH, RI = H)32 and (38;
R = RI = OH)33 can be removed by hydrogeno1ysis of the l-phenyl-
tetrazol-S-yl ethers. The corresponding 4-ethers were not prepared
but it seemed reasonable that these too might be hydrogenolysed.
Alkylation of S-dihydrothebaine (27) with 5-chloro-l-phenyl-
tetrazole proceeded slowly but in acceptable yield to give the ether
{39}. A series of derivatives analogous to those in section 2.1 was
20
R
NCHO
(38)
then prepared (Scheme IV). Various attempts (see Experimental) were
made to hydrogenolyse off the phenyltetrazolyloxy group from the
cycloadduct (40) and the thebainones (41) and (42). All met with
failure and starting material was recovered.
Due to the difficulties encountered, this procedure for the
preparation of l4-acylaminodeoxydihydrocodeinones was abandoned and
with it the original aim of the project.
Me
PhCH 2CH 2CONHOH
NMe NaI04
(39 )
MeO
RO 502, pyridine
NMe
(42)
SCHEME IV
21
MeO
RO
MeO
(40)
MeO
RO
NMe
(OH)COCH2CH2Ph
(41)
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CHAPTER 3
ATTEMPTED ROUTES TO A N-C(14)-BRIDGED CODEINONE DERIVATIVE
The pharmacological importance of the substituent on the
piperidine nitrogen has already been noted. In morphine, X-ray studies
have shown that this methyl group occupies an equatorial position on
the pip~r;d;ne ring,34 but on binding to the receptor the conformation
of the molecule may be altered. In the antagonists, where the
piperidine nitrogen alkyl group is considerably more flexible, no
details are known about the conformation adopted either in the crystal-
line state or bound to the receptor. Moreover, it is possible that
the N-alkyl group adopts different (axial or equatorial) conformations
in agonists and antagonists when the drugs are so bound.
Our aim was to prepare a codeinone derivative, for example
(43; R = H), in which the piperidine nitrogen substituent was linked
(43)
to the l4-position to form a rigid structure of known stereochemistry.
Further modifications, reduction of the amide carbonyl group and the
introduction of alkyl side chains (R) would lead to a new series of
compounds in which the piperidine nitrogen substituent is unambiguously
23
axial. The structure-activity relationships for such a series may
give some insight into the receptor site and how the morphine
derivatives are bound.
To date, only one example of a piperidine-N-C(14) bridge has
been reported. Merz and POOk35 discovered that when thebaine was
treated with two equivalents of ethyl azodicarboxylate and the
reaction mixture hydrolysed with acid, the hexacyclic derivative (44)
was obtained. Equimolar quantities of thebaine and ethyl azodi~arb-
oxylate gave N-(l ,2-diethoxycarbonylhydrazinomethyl )northebaine (45),
Mea
C02Et
/""'...~./~ - CO2 Et
H
Mea
(44) (45)
an intermediate in the preparation of northebaine (see section 3.1).
The mechanism of formation of (44) was partially deduced from the
reaction of N-trifluoroacetylnorthebaine (2; NCOCF3 for NMe) with
ethyl azodicarboxylate which yielded the normal Diels-Alder adduct
(46) and which could be transformed into (44) by a three step sequence.
The mechanism proposed for the formation of (44) involved formation
of the Diels-Alder adduct which rearranged and hydrolysed.
Thebaine
24
MeO
NCOCF 3
(46 )
- (45) -
1
(44) -
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The tertiary base (47), recently reported by Fleischhacker and
Richter,36 contains a N-C(14) bridge but the integrity of the morphine
skeleton has been destroyed. Cleavage of the N-C(9) bond also features
in the preparation, by two groups of workers,37,38 of the enol ether
(48) .
(47) (48)
3.1 8y an Intramolecular Diels-Alder Reaction
In the first route considered (Scheme V) the prospective bridge
atoms were in the form of a hydroxamic acid group on the piperidine
nitrogen. Cyclisation should thus be accomplished by an intramolecular
Diels-Alder reaction of the related nitrosocarbonyl compound. By a
series of similar reactions to those discussed in Chapter 2, viz.
ring opening, reduction and hydrolysis, this adduct should be
transformed into the bridged codeinone (43).
Northebaine (49) was prepared by the method of Eli Lilley and Co.39
although there are other preparations available.4o Thebaine was
treated with one equivalent of ethyl azodicarboxylate to give the
intermediate (45) which was hydrolysed with ammonium hydroxide to
northebaine (49).
Bentley et aZ.8C have prepared a large number of N-alkyl-,
(49 )
(52)
(43)
10 -1+
Mea
(50)
1NH20H
(51 )
26
N~aEt
a
N~NHOH
o
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N-alkenyl- and N-alkynyl-norbases but no ester derivatives were
synthesised. Nevertheless, the general experimental procedure was
followed and an overnight reflux in anhydrous acetone with ethyl
chloroacetate with anhydrous potassium carbonate converted northebaine
into ~ethoxycarbonylmethylnorthebaine (50) in high yield. A 45 min
reflux in dimethylformamide also realized this conversion.
The most common method for the preparation of hydroxamic acids
from esters is by treatment with hydroxylamine, freed from its hydro-
chloride in situ with sodium hydroxide solution.41 Under these
conditions the expected derivative (51) was isolated, although in low
yield and as an impure foam even after chromatography. The impurities,
identified from the mass spectrum, were the corresponding carboxylic
acid (C2oH21NOs' M+ 355.1418) and amide (C2oH22N204' M+ 354.1561).
In an attempt to form the cyclised adduct (52) the hydroxamic
acid was treated with sodium periodate. A t.l.c. of the product after
work-up indicated that it was a mixture of at least six compounds, none
of which was isolated or identified.
Due to the failure of the key reaction and the unsatisfactory
preparation of the hydroxamic acid this route to the cyc1ised compound
(52) was abandoned.
3.2 By a Nucleophilic Substitution Reaction
This approach to (43), outlined in Scheme VI (R = H) envisages
cyc1isation as nucleophilic displacement of the chlorine by the
piperidine nitrogen.
a-Chloroacetohydroxamic acid (C1CH2CONHOH) was prepared by the
method of Jones and Werner.42 Although the mass spectrum showed the
molecular ion at m/z 109, 111, the melting point differed from that
in the literature by ~10°C and the n.m.r. resonance at 07.30
28
~O
C1CH2CONHOH
NaI04NR
~O
(49) (53)
t
~O
(43)
~O
(52)
SCHEME VI
(exchangeable with °20) integrated as seven protons. Repeated
analyses varied greatly, particularly in the value for nitrogen
(5 - 10%) low and the exact composition of this hydroxamic acid was
never established. Nevertheless, using three equivalents of both this
compound and of periodate, Diels-A1der adducts of thebaine derivatives
were successfully prepared (see p. 29 and 31). But, with northebaine
the oxidation resulted in a mixture of products being obtained and
their formation was largely attributed to the nucleophilic nitrogen
reacting with the nitrosocarbonyl compound.
29
To overcome these complications, northebaine was converted into
crystalline, and easily prepared, N-t-butoxycarbonyl derivative43
(49; R = C02But). This compound was treated with nitrosocarbonyl-
chloromethane (C1CH2CONO), generated from a-chloroacetohydroxamic acid
and tetraethylammonium periodate,44 and the expected cycloadduct
(53; R = C02But) was isolated in quantitative yield. The above
oxidising agent, unlike sodium periodate, is soluble in organic solvents
and so the reaction was carried out in a homogeneous solution. The
inability of sodium periodate in the two-phase solvent system to bring
about this reaction was presumably a consequence of the low solubility
of. the amide (49; R = C02But) in water.
Initial attempts to recrystallise the crude adduct from hot
ethanol caused cleavage of the chloroacetyl moeity and, on the basis
of further experimentation, it appeared that the cause was water
dissolved in the ethanol. The product isolated was identified as the
codeinone (54) from its spectroscopic properties and by rearrangement
with sodium ethoxide to the phenol (55). The crude cycloadduct was
essentially pure by n.m.r. and, due to its sensitivity towards hydrolysis,
(54) (55)
30
was used without purification in subsequent reactions.
t-Butoxycarbonyl groups are easily removed under mild acidic
conditions,45 conditions similar to those required for the hydrolysis
of cycloadducts and the protection of the resulting codeinones as
their ethylene acetals. However, the compound isolated from the
reaction, in methylene chloride, between the cycloadduct (53; R = C02But)
and anhydrous hydrogen chloride in ethylene glycol was the ethylene acetal
(56) •
MeO
NC02But
N(OH)COCH2Cl
(56)
The unsuccessful deprotection of the piperidine nitrogen was attributed
to a lack of acidity and so more forcing conditions were applied to
the cycloadduct. 10% Anhydrous hydrogen chloride in ethyl acetate
achieved this deprotection, but it was accompanied by the rearrangement
[ (57) -+- (58)].
MeO
-NH
~
'(1"11)\ ClHO 0
(57) (58)
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Failure to produce a purple colour with ferric chloride solution was
the first indication that the hydroxamic acid (57) had not been
isolated. The mass spectral fragmentation pattern was crucial in
identifying the product as the hydroxylamine (58). Table 1 lists
the high mass fragment ions of the product (58), and for comparison
those of the hydroxylamine (54) and the hydroxamic acid (56).
In (58), the chloroacetyl moi~ty was lost after the elimination
of either nitric oxide or the nitroso species HNO. There were no peaks
corresponding to an initial loss of chloroacetyl or parts thereof.
This sequence of events, whereby the NO or HNO fragment was lost
independently of the piperidine nitrogen side chain was paralleled
in the hydroxylamine (54). A different mode of decomposition was
observed for the molecular ion of the hydroxamic acid (56).
The yield of the hydroxylamine (58) after purification by column
chromatography and crystallisation was 14%. The mother1iquors from
the crystallisation contained the major component of the reaction -
a chlorinated derivative of (58) resulting from addition of hydrogen
chloride to the 7,8 double bond. It was later found that the rearranged
product could be obtained directly from the cycloadduct and in higher
yield (37%) by carrying out the reaction in anhydrous methylene
chloride.
The mechanism of chloroacety1 migrations appears to involve
nucleophilic attack by the piperidine nitrogen at the carbonyl group
leading to the formation of a five membered cyclic intermediate. This
result was surprising in the light of subsequent work in the thebaine
series.
The thebaine cycloadduct (59) was prepared in the usual manner
with sodium periodate as the oxidiser (af. p. 29). However, attempts
to crystallise this crude adduct resulted in cyclisation to the
\
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TABLE 1
Compound Fragments (% rel. to base peak)
MeO
COCH2C1
N-H
I
OH
(58)
MeO
NC02Bu
t
N-H
I
OH
(54)
(56)
*434.1267 (0.8); [M]-i;
418. 1313 (4. 1 ); [M-O'] +
406.1208 (7.7),404.1234 (31.5); [M-NO]"!"
405.1254 (4.0), 403.1150 (8.6); [M-HNO]"!"
311.1246 (5.5); [M-NO-NH2COCH2C1]-i;
310.1200 (6.9): [M-HNO-NH2COCH2Cl]t
414.1783 (6.1); [M]!
398.1844 (0.5); [M-O']+
+384.1769 (1.8); [M-NO]·
383.1744 (8.7); [M-HNO]!
358.1138 (58.6); [M-C4Ha]!
341.1154 (33.7); [M-C4Ha-OOH]+
328.1187 (15.8); [M-NO-C4Ha]"!"
327. 1118 (18.2); [M-HNO-C4Ha]!
313.1191 (2.1); [M-COzBut]+
282.1126 (10.6); [M-HNO-C02But] +
536.1741 (10.4),534.1750 (28.8); [M]t
+480.1107 (15.1), 478.1114 (42.2); [M-C4Ha]'
463.1107 (1.7), 461.1099 (5.4); [M-C4Ha-OOH]+
427.1965 (8.4); [M-N(0)COCH2C1]t
+371.1341 (100); [M-C4Ha-N(O)COCH2C1]·
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MeO MeO
MeO MeO
(59) (60)
quaternary ammonium salt (60). Treatment of the cycloadduct with anhydrous
hydrogen chloride in ethylene glycol gave the quaternary ammonium chloride
(61), presumably formed from the open-chain hydroxamic acid which was not
isolated. This type ofcyclisation to a six-membered ring was exactly that
(61)
hoped for with the northebaine derivative (52). However, in that
case attack at the carbonyl group can lead to a stable product.
Although the rearranged compound had not been the objective
it still possessed the component parts of a bridge between the
nitrogens. Two modes of cyclisation were conceivable, either attack
by the hydroxylamine nitrogen on the methylene group with
34
displacement of chlorine leading to a six-membered ring or the
corresponding attack from the hydroxylamine oxygen to form a seven-
membered ring. In attempts to achieve either cyclisation (58) was
heated in ethanol, toluene, acetone, dimethylformamide and dimethyl-
formamide-triethylamine. Starting material was recovered in all but
the last experiment when decomposition took place.
The quaternary ammonium chlorides from the thebaine series were
the only compounds obtained with a bridge between the piperidine
nitrogen and the 14-position.
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CHAPTER 4
a-LACTAMS
"I'm cal.led Little Buttercup - dear little Buttercup,
Though I could never tel.l: why. "
W.S. Gilbert from H.M.S. Pinafore Act I.
This chapter describes novel reactions of thebaine derivatives
and some related model compounds which are thought to proceed through
a-lactam intermediates. It is appropriate therefore to review briefly
the relevant chemistry of a-lactams.
«-Lac tems or aziridin-2-ones (62; R,R',R" = alkyl, aryl) are
three membered cyclic amides. Heterocycles such as these have been
postulated as reactive intermediates in, for example, the reaction of
diazomethane with phenyl isocyanate46 (Scheme VII), the reaction of
oxaziranes with diphenylketene47 (Scheme VIII), and the thermal
rearrangement of N-ary1-isoxazo1in-3-pnes48(Scheme IX).
(62)
The synthesis of the first authentic a-lactam (63) was reported
by Baumgarten in 196249 and involved cyclisation of N-chloro-N-t-butyl-
phenyl acetamide with potassium t-butoxide. Later a more general
synthesis of a-1actamsSO,Sl was developed in which a-halo-amides (64)
were treated with base, usually potassium t-butoxide, in a dry inert
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o
BU~ ~Ph
N
I
H
o
BU~N~Ph
I
Cl
(63 )
solvent. Two other methods have been reported. Addition of dichloro-
carbene to N-neopentylidene-t-butylamine gave the dichloroaziridinewhich
o
R Jl /RI
'~.,l'R"
H X
base--
(64 )
was treated with aqueous sodium hydrogen carbonate.52 Also, the reaction
between some amino acids and phosgene in the presence of triethylamine53
has been reported to give ~-lactams.
In each of the ~-lactams which have been isolated, the heterocyclic
ring is stabilised by the presence of a bulky group (t-butyl or l-adamantyl)
on the nitrogen. These compounds are also either mono or disubstituted
at C-3 with a variety of alkyl or aryl groups. Bicyclic spiro ~-lactams
are also known.54
The «-Jec tan ring is opened by nucleophilic attack, for example, of
alkoxide or halide ion at C-3 to yield the appropriate ~-substituted
amides (64; X = alkoxy or halo). Generally Grignard reagents (RillMgX)
also attack the ~-carbon atom of ~-lactams and cleave the alkyl carbon-
nitrogen bond although, with highly sterically hindered species, attack
takes place at the carbonyl carbon. The reagent and reaction conditions
used also influence the reaction pathway and thus the type of product(s)
isolated. For example, CL-halo-amides,55 CL-hydroxy imines56,57 (65) and
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a-alkyl amides [together with (65) J57 have been independently obtained
from Grignard reactions. Organolithium reagents (R"ILi) preferentially
attack the carbonyl carbon of a-lactams to give a-amino ketones (66)
or by further addi tion, the tertiary alcohols. 58
R"
R-N=CRI-~(RIII
OH
RI
R, I ,00
N-C-C /'
H/ I 'RillRII
(65) (66)
4.1 In Experiments with Thebaine Derivatives
Since a sulphur atom is midway in size between a one-carbon and
a two-carbon chain, amide side chains at position 14 in thebaine
derivatives incorporating such an atom would be slightly different in
length from their known carbon analogues. Also, the presence of
sulphur would modify the lipophilic properties of the derivatives and
permit syntheses of the more polar sulphoxides and sulphones. In both
the northebaine derivatives (53; R = C02But) and (56) substitution of
the chlorine atom by a mercapto group followed by a series of reactions
similar to those discussed earlier would lead to the novel compounds
(67; RI = alkyl, aryl).
To this end, the hydroxamic acid (56) was treated in ethanol for
1 h at room temperature with one equivalent each of thiophenol and
sodium ethoxide. Work-up afforded one compound which was identified as
the l4-aminocodeinone derivative (68) (see Chapter 5 for a detailed
discussion). As apparently the thiophenol was not involved in this
transformation, a similar experiment without the thiophenol was carried
out. The amine (68) was isolated in 44% yield.
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Mea
N(OH)COCH2Cl
t(53; R = C02Bu ) (56)
14 NH
NHCOCH2SR'o
(67) (68)
An alternative approach using the cycloadduct (53; R = C02But)
was therefore investigated. The stability of (53; R = C02But) towards
sodium ethoxide was studied first. Thus, treatment of the cycloadduct
with an excess of sodium ethoxide solution in ethanol gave a mixture
of products. However, one compound crystallised (20% yield) from an
ethyl acetate solution of this mixture and was identified as the
norcodeinone (69) from its spectroscopic properties. Thus the mass
spectrum showed a molecular ion at m/z 528.2484 but apart from this
no significant peaks in the high mass region were observed. The 1H
n.m.r. spectrum contained a two-proton singlet at 06.22 arising from
40
MeO
o
7
(69 )
7-H and 8-H, and signals due to a t-butyl group (01.47) and an aromatic
methoxy group (03.85). Also present in the spectrum were two methine
singlets at 04.72 and 5.09 and that at lower field was attributed to
5-H by comparison with a related spectrum (see below). Evidence for
the diethy1 acetal moie,ty of the side chain was obtained from the IH \-
j
n.m.r. spectrum by the presence of a singlet at 04.72, two triplets at
01.20 (J 7 Hz) and 1.24 (J 7 Hz) and a broad quintet (two overlapping
quartets) at 03.62 (J 7 Hz). Absorptions in the i .r. at 3 390 and
1 695 cm-1 suggested the existence of an amide group. 13C N.m.r.
chemical shifts also agreed with the structure and are shown in
Figure 1. Carbons 1-16 were assigned by comparison with literature
va1ues .59 ,60
Reduction of (69) with sodium borohydride in ethanol gave the
norcodeinone (70). In the lH n.m.r. spectrum of (70) the C~(OEt)2
proton gave a sharp singlet at 04.70 whereas 5-H, together with 6-H,
gave a broad hump at 04.95. This established the assignments of the
singlets at 04.72 and 5.09 in the IH n.m.r. spectrum of the nor-
codeinone (69) (see above).
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115.54
(69)
FIGURE 1
MeG MeD
HO
oH
(70) (71 )
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Acid catalysed hydrolysis of a diethyl acetal such as (69) should
give the corresponding aldehyde. Thus the acetal (69) was dissolved in
methanol and treated with aqueous hydrochloric acid for 30 min at 60°C.
However a basic work-up only afforded a low yield of the dimethyl
acetal (71).
o
..--:; N~X
0/ H
~OEt
-
Mea
o
~;YX
H OEt
o
~
~ ~ x
90Eto
(69) (72)
X = Cl or OEt
SCHEME X
The mechanism proposed for the formation of the norcodeinone (69)
from the cycloadduct (53; R = C02But) is illustrated in Scheme X.
Initial removal of an acidic methylene proton by ethoxide generates a
carbanion which attacks the nitrogen. Concomitant cleavage of the
nitrogen-oxygen bond and elimination of the 6-methoxy group gives the
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a-lactam intermediate (72). Nucleophilic attack by ethoxide at the
~-carbon of (72) followed by cleavage of the alkyl carbon-nitrogen
bond gives the norcodeinone (69). To account for the nature of the
terminal part of the side-chain, substitution of the chlorine by an
ethoxy group must also be included in the above Scheme.
Further investigations into this novel reaction were carried out
with the readily available thebaine cycloadducts. Initially the
cycloadduct (73; R = H) was prepared and treated with sodium ethoxide.
Refluxing in ethanol for 5 h with one equivalent of the base yielded
only the starting cycloadduct. This result suggested that the ethoxide
was failing to abstract one of the methyl hydrogens, presumably due to
a lack of acidity of the latter.
MeD
NMe
~ aMeD ~NCOCH2R
o
(73)
An electron withdrawing group such as phenyl or indeed chlorine
on the a-carbon should increase the acidity of the neighbouring hydrogens
and thus facilitate hydrogen abstraction. Accordingly, the cycloadduct
(73; R = Ph) was prepared and treated with one equivalent of sodium
ethoxide. Early attempts at this reaction afforded the product (74)
as a mixture of two diastereoisomers. The IH n.m.r. spectrum of the
mixture was in effect two superimposed spectra, i.e, there were two
distinct resonances for each of the following: N-H, 5-H, 7-H, 8-H,and
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NMe
o
~~OEt
Ph H
(74)
the various protons in the CHOCH2CH3 moeity. With careful control
of the reaction time (30 min at room temperature) and work-up
(see Experimental) the product consisted largely of a single
diastereoisomer which was obtained pure and crystalline. It was
also found that treatment of the cycloadduct with a catalytic amount
of the base for 65 h yielded the same diastereoisomer and that the
pure diastereoisomer could be partially converted into the other
isomer with sodium ethoxide.
Furthermore, treatment of the cycloadduct (73; R = Ph) with
sodium methoxide in methanol at room temperature overnight (16 h)
yielded only one diastereoisomer (75a), which was shown to have the
(S)-configuration at the new chiral centre (see p • 46 ). Under more
Me MeO
NMe
o
C~OMePh / H o
(75a) (76)
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severe reaction conditions (an overnight reflux with sodium methoxide)
the cycloadduct was converted into the diastereoisomeric mixture. In
the presence of sodium deuteriomethoxide and methanol-d4 the cyclo-
adduct reacted to yield a crystalline mixture of the tri- and tetra-
deuterio analogues of the (S)-diastereoisomer (76) in the ratio 3:2.
The IH n.m.r. spectrum of (76) lacked the resonance due to the side-
chain methoxy protons and, from the integration, only 40% of the
molecules contained a benzylic hydrogen (04.54). Thus the rate of
~-lactam formation was approximately equal to that of deuterium
exchange in the cycloadduct.
A 13C n.m.r. spectrum of the (S)-diastereoisomer (75a) was
recorded and Figure 2 illustrates the signal assignment. Annotated
56.93
CH3
21 .20
'~----k 46.02
____ 62.97
42.74
NCH3o
not present in
the spectrum of
(76); the 3-0CH3
signa' occurred
at 056.92
/
135.62
57.26
>-84-.5-'-OCH 3
137.10 "
~decreased in size
in the spectrum
of (76)126.85
(75)
FIGURE 2
46
on the diagram are the salient differences between this spectrum and
the 13C n.m.r. spectrum of the deuteriated mixture (76).
To establish the configuration of the new chiral centre in (7Sa)
14s-aminocodeinone (77, supplied by Reckitt and Colman Products Ltd.)
was coupled, in parallel experiments using dicyclohexylcarbodiimide,
with (5)-(+)- and (R)-(-)-a-methoxyphenylacetic acid (Scheme XI).
These acids were prepared according to the literature method61 by
methylating (5)-(+)- and (R)-(-)-a-mandelic acid with dimethyl sulphate.
MeO
NMe
~~O
H )::-:O~1e
Ph "'H
(8)-(+)
MeO
(7Sb)
o
NMe Ph
H02C--(
Mea 'H Mea
NMe
N~aIH _ Ph
MeD "H
(77)
(R)-(-)
(78)
S.CHEME XI
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The ~ n.m.r. chemical shifts and the melting points of the
above pair of diastereoisomers were compared with those of the
stereoselective reaction product (75a) and the relevant details are
given in Table 2. Thus the close agreement in the data cited for
(75a) and (75b) proved that the new chiral centre in (75a) possessed
the (S)-configuration.
TABLE 2
(75a) (75b) (78)
cS(CHOC.!:!3) 3.37 3.38 3.43
cS(CHPh) 4.54 4.55 4.58
cS(5-H) 4.69 4.68 4.93
cS(7-H and 8-H) 6.20 6.19 6.06
o( Ph) 7.41 (br s) 7.25-7.55 (m) 7.32 (s)
m.p. (0C) 178-179 178-179 202-203
In view of this conclusion it was proposed that in the
aforementioned reaction the a-lactam with the (R)-configuration at
C-31 was fanned stereoselectively and, attack by methoxide at this
position gave the desired product (Scheme XII). The benzylic hydrogens
in (73; R = Ph) are chemically different, they are diastereotopic,
but in an examination of the molecular model of this compound the
(pPO-R)-hydrogen did not appear to occupy more advantageous positions,
with respect to abstraction, than those of the (ppo-S)-hydrogen. It
appears therefore that the selectivity in the reaction must reflect
the preferred orientation of the carbanion at the moment of attack on
nitrogen.
The diastereoisomers (75) and (78) were tested for pharmacological
activity but at the time of writing the results were not known.
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MeD
-HR-
(73; R = Ph) I
O~~~OMe
Ph H
(75a)
SCHEME XII
In the preamble to this chapter it was noted that the first
authentic a-lactam was prepared through cyclisation of N-chloro-N-
t-butylphenylacetamide. The structural similarity between this amide
and the o-tosyl hydroxamic acid (80) suggested that this latter
compound should cyclise with base to give an a-lactam, identical to
that postulated in the stereoselective reaction. Thus, in the presence
of sodium methoxide, the tosylate (80) should be converted via an
a-lactam, into the diastereoisomer (75) (Scheme XIII).
Acid catalysed hydrolysis of the cycloadduct (73; R = Ph) yielded
the hydroxamic acid (79) which crystallised from chloroform-methanol as
the hemi-hydrate. The structure of this hydroxamic acid was confirmed
by its conversion, with sodium ethoxide in ethanol, into the phenol
(81 ) •
Mea
TsCl,
NMe pyridine
o
~ I~PhHO
(79)
MeO
NMe
a
~- __ OMe
Hph~
(75 )
SCHEME XIII
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MeO
NMe
I--<-Ph
OTs
(80)
1NaOMe
Mea
NMe
N~O
\L_Ph
(81)
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Attempted tosylation of the hydroxamic acid (79) with toluene-
p-sulphonyl chloride in pyridine resulted, after an aqueous work-up,
in the isolation of an orange gum. The IH n.m.r. spectrum of this
material contained a large number of signals particularly in the
aromatic region. A singlet at 02.52 (C~3C6H4) in the spectrum suggested
that the desired tosylate (80) may have been one of the reaction products.
In an optimistic experiment, the crude residue from the tosylate reaction
was treated with sodium methoxide in methanol (see Experimental) in the
hope that any tosylate formed would be converted into the diastereo-
isomer (75).
However, much to our surprise, a yellow compound [30% from the
hydroxamic acid (79)] crystallised from this solution. On account of
its yellow colour the compound was named 'buttercup' and was eventually
assigned the structure of the anhydro-base (82) from its spectroscopic
properties and by comparison with model compounds.
5'
(82)
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The mass spectrum revealed a molecular formula C3lH2~304 which,
when compared with that of the starting material (79) (C26H26N2D 5)'
suggested the incorporation of a molecule of pyridine with loss of
water and, surprisingly, loss of two hydrogens. The lH n.m.r. spectrum,
recorded at 250 MHz in COC13 (Figure 3), exhibited the usual O-methyl
and N-methyl resonances at 03.90 and 2.19 respectively. Singlets at
04.59 (lH) and 7.51 (5H) were assigned to 5-H and the mono-substituted
benzene ring, and the aromatic protons l-H and 2-H gave an AB quartet
(06.55 and 6.72). The broad one-proton resonance at 07.56 (partly
obscured by the Ph signal) disappeared on addition of 020 and this,
together with absorptions at 3 415 and 1 720 cm-1 in the i .r. spectrum
indicated the secondary amide function. The remaining four low-field
protons, which appeared as distinct multiplets, formed the ABCD system
of the reduced pyridine ring. Analysis of this system is shown in
Table 3.
Further evidence for a reduced pyridine ring in buttercup was
obtained by carrying out the attempted tosylation reaction in
pyridine-ds. The residue from this procedure was treated with sodium
methoxide in methanol as before. A mass spectrum of the resulting
yellow needles showed a molecular ion at m/z 509.2255 which corresponded
to the formula C31H2304N304' The IH n.m.r. spectrum was identical to
that shown in Figure 3 except that the four multiplets cited in Table 3
were missing. Furthermore, doublets at 0112.81, 118.62, 134.56, and
140.59 in the 13C n.m.r. spectrum of (82) (see Figure 4 for signal
assignment) were absent in the analogous spectrum of the deuteriated
rnaterial.
The methine singlet at 03.83 in the lH n.m.r. spectrum was
eventually assigned to 8-H and this signal was considerably sharpened
upon addition of 020. It was concluded, therefore, that 8-H was
weakly coupled to N-H. The appearance of a sharp singlet at 03.49 (l.5H)
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115.76
22.05
_--H:tS .85
__ 63.95
43.22
129.73a
1 34 .56
(82)
a Assignments may be reversed. b Obscured by signals at aa. 6130.
FIGURE 4
suggested that buttercup had been isolated as the hemi-methanolate.
However, as the most satisfactory elemental analysis obtained corresponded
to the hydrate-hemi-methanolate the exact composition of the yellow
crystals was in doubt.
The U.V. spectrum of buttercup showed two strong absorptions at
339.5 and 435 nm due to the ~ ~ ~* transitions of the extended dihydro-
pyridine chromophore. On addition of trifluoroacetic acid the
55
dihydropyridine system was aromatised and the resulting pyridinium
trifluoroacetate gave rise to a new u.v. spectrum (Amax 352 nm). This
reaction was reversible; addition of base regenerated the dihydro-
pyridine system with the u.v. absorption bands at 339.5 and 435 nm.
o acid o
base
Yellow Colourless
Amax 339.5, 435 nm Amax 352 nm
The most notable feature in the i.r. spectrum was a strong ketone
carbonyl absorption at 1 485 em-I. This, together with an abnormally
high-field signal for C-6 in the I3C n.m.r. spectrum emphasised the
importance of the zwitterionic formulation:
o
56
The structure of buttercup was confirmed by comparison with
model compounds. Several N-alkylated anhydro-bases have been reported
in the literature, and those which most closely resemble the substituted
dihydropyridine moeity of buttercup are (83a),62,63 (83b),64 and (83c).65
All the spectroscopic data documented for these three compounds (see
Table 4) are in good agreement with those obtained for buttercup.
4503 Iq
6l!..N~RI
I 1
R
(83)
a; R = Me, RI = Ph
b; R = CH2Ph, RI = Ph
c; R = CH2Ph, RI = Me
d; R = RI = Me
TABLE 4
Compound \/max in cm-1 A in nm (E) A + Helmax max
83a 1 501 (C=O)
83b - 255 (15 300), 340 (12 800), 260 (27 000)
422 (27 400)
83c 1 505 (C=O)
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With the view to obtaining IH and 13C n.m.r. spectra for further
comparative purposes the anhydro-base (83c) and the hitherto unknown
compound (83d) were prepared (Scheme XIV). The model compound (84),
which was named 'neo-buttercup', was also synthesised (see later) in
order to obtain evidence for the mechanism of formation of buttercup.
o
5'
(84)
The IH n.m.r. spectrum of (84) is shown in Figure 5 and the
13C n.m.r. signal assignments of (83c), (83d), and (84) are illustrated
in Figure 6. The pertinent spectroscopic data of buttercup and those
of the model compounds are collated in Tables 5 and 6.
Generally the spectroscopic data of buttercup compares well with
those of the model compounds. In particular, the abnormally low
frequencies of the ketone carbonyl absorption in the i.r. spectrum and
the carbonyl carbon resonances in the 13C n.m.r. spectrum of each of
the model compounds closely parallel those of buttercup. Thus each of
the four anhydro-bases has pronounced zwitterionic character.
The u.v. spectrum of buttercup and of neo-buttercup is shifted to
longer wavelength compared with that of (83c) and (83d) and this may be a resul t
of as light twist in the conjugated systemineach of the molecules (al. ref. 66).
In the IH n.m.r spectrum of buttercup and of nee-buttercup the 61-H signal
is aa. 0.5-1 p.p.m. upfield of the corresponding signal in (83c) and (83d).
NaOH1
(83d)
1
1. PhLi, ether
2. CH3CN
3. He
SCHEME XIV
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57.52
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remaining aromatics: 126.77,129.11
(83c)
109.19
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87.39 CH3
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CH3
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remaining aromatics: 128.90, 130.64.
t multiplicities not observed.
(84)
Note: Spectrum of (84) recorded in CD30D due to insolubility of sample
in CDC13•
FIGURE 6
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TABLE 5
I.r.a and u.v.b spectral data
Compound vmax (cm-I) (C=O) >max (nm) >max + TFA
82 1 485; 1 48Sc 339.5, 435 352
84 1 500; 1 50ac 336, 435 360
83c 1 505 326, 396 346
83d 1 505 322, 390 340
a KBr discs unless otherwise stated. b In EtOH. c In CHC13.
TABLE 6
Comparison of IHa and I3C n.m.r. chemical shifts (0) in the dihydro-
pyridine ring
Compound 4-H 3-H 5-H 6-H cC=O
82b 6.40 (dt) 7.01 (br td) 7.42 (ddd) 7.97 (br td) 178.32
84b 6.14 (dt) 7.05 (td) 7.23 (ddd) 7.65 (td) 190.20
83c 6.18 (dt) 7.00 - 7.55 (m) 8.93 (dd) 191 .35
83d 6.13 (dt) 6.96 - 7.25 (m) 8.88 (td) 190.95
a 250 MHz for (82) and (84). b Numbering superscripts omitted for
clarity. c Normal values for unsaturated ketones ca. 200 p.p.m.
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An examination of molecular models revealed that in the more favourable
conformations of (82) and (84) the benzene ring lies over 51-H, i.e.
this proton is shielded and thus resonates at higher field.
In buttercup, and in neo-buttercup, the lactam and pyrro1ine
rings were reasoned to be cis-fused since the corresponding trans-fused
system would be very highly strained.
The mechanism proposed for the formation of buttercup (82) from
the hydroxamic acid (79) is shown in Scheme XV. After initial formation
of the tosylate, removal by pyridine of one of the benzylic protons
leads to the production of an a-lactam intermediate. Nucleophilic
ring opening by pyridine gives the pyridinium chloride (85), which
presumably is the crude material isolated from the reaction. Sodium
methoxide abstracts the remaining acidic proton to generate an y1id
which adds, as a 1,3-dipo1e, to the double bond of the enone. Finally,
aromatisation of this dihydropyridine gives buttercup.
Similarly, neo-buttercup (84) was obtained from the hydroxamic
acid (88) (see Scheme XVI) by treatment with to1uene-p-su1phonyl chloride
in pyridine followed by sodium methoxide in methanol. The required
starting hydroxamic acid was prepared in three steps from p-methylaniso1e.
Monti et aZ.67 have reported that Birch reduction of p-methy1anisole
with lithium in dry liquid ammonia containing t-butanol and tetrahydro-
furan gives a high yield (78%) of 1-methoxy-4-methy1-1 ,4-cyc1ohexadiene.
In our hands this procedure gave a 1:1 mixture of the 1,4- and 1,3-dienes
in 76% yield. Further equilibration of this material with a catalytic
amount of toluene-p-su1phonic acid afforded, after distillation, a
colourless oil which contained 72% of the desired 1,3-diene and 28% of
the 1,4-diene. Treatment of this oil with phenylacetohydroxamic acid
and sodium periodate in ethyl acetate and aqueous buffer (pH 5.8) yielded
a complex mixture of products. The crude mixture was chromatographed on
a column of silica but only one component (21%), identified as the
o
N~Ph TsCl,
6H pyri dine
(79)
(85)
INaOMe
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\ hydroxamic acid (88), was obtained pure and crystalline. The other
products were eluted from the column as oily mixtures and were not
identified. Presumably the hydroxamic acid was formed by hydrolysis
of the cycloadduct (87), the expected product.
As the cycloadduct (87) was desirable as a model for the stereo-
selective reaction, attempts were made to obtain it from the above
oxidation by modifying the experimental conditions. Thus, by using
a variety of buffers the oxidation was carried out at pH 6.8,7.5,
and 9.2 but in each case mixtures ensued which were not investigated
further. A mixture was also obtained when the reaction was repeated
with tetraethylammonium periodate as oxidant.
Circumstantial evidence supporting the formation of an a-lactam
intermediate in the reaction leading to buttercup was obtained as
follows. In a procedure developed with aliphatic hydroxamic acids
(see Section 4.2), the model hydroxamic acid (88) was treated with
trifluoromethanesulphonic anhydride in methylene chloride containing
triethylamine at -70°C. An i .r. spectrum of the reaction mixture
showed an intense absorption band at 1 845 cm-1 indicating the presence
of an a-lactam. Pyridine was added to the reaction mixture at -70°C,
the solution allowed to attain room temperature and the solvent was
then evaporated. Treatment of the residue with sodium methoxide as
before yielded neo-buttercup. A similar procedure on the thebaine
hydroxamic acid (79) failed to show any sign of an ci-lactam but this
could be due to interference in the reaction by the tertiary amine
group.
The compound isolated from the reaction between the hydroxamic
acid (79) and toluene-p-sulphonyl chloride and pyridine was believed
to be the pyridinium chloride (85). To prove this hypothesis, an
authentic sample of this salt was required so that upon treatment
with sodium methoxide it would be converted into buttercup. To this
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end, the a-chloro-amide (89), prepared from 14s-aminocodeinone and
(±)-a-chlorophenylacetyl chloride, was treated with pyridine under
several sets of reaction conditions (see Experimental). The chloro-
amide was either recovered from the experiment or was decomposed by it.
MeO
NMe
o
~~Cl
Ph H
(89)
The final step in the proposed mechanism for the formation of
buttercup involves dehydrogenation of a dihydropyridine (see Scheme XV).
In an attempt to discover whether it involved atmospheric oxygen, the
crude residue obtained from the first stage of the reaction was
treated with sodium methoxide under oxygen-free nitrogen conditions.
As buttercup was isolated in approximately the same yield and at
approximately the same rate as before the oxidation was apparently not
caused by oxygen in the air.
4.2 In Experiments with Aliphatic Compounds
The novel reactions discussed in Section 4.1 are thought to proceed
via a-lactams which, in each case, are formed from hydroxamic acid
derivatives. As part of a further investigation into these reactions
the preparation of the model hydroxamic acid (93) was undertaken with
the aim of subjecting it to reactions similar to those described earlier.
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(93)
Perkins and co-workers68 have reported the synthesis of
N-t-butylphenylacetohydroxamic acid (93) in three steps from
N-t-butylhydroxylamine (90) (Scheme XVII). Acetylation with acetic
-7-~-H
OH
i- 7-~-H
OAc
i i-
(90) (91) (92)
(93)
SCHEME XVII Reagents: i, AczO-K2C03-ether; ii, PhCH2COCl -pyridine-
benzene; iii, Ba(OH)2-ethano1.
anhydride gave the o-acetyl derivative (91) which was converted into
the diacylhydroxylamine (92) by treatment with pheny1acetyl chloride
in benzene containing pyridine. Removal of the o-acetyl group with
barium hydroxide afforded the hydroxamic acid (93).
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The attempted phenylacetylation under the literature conditions
gave a 30% yield of the a-chloro-N-t-butylphenylacetamide (94).
o
~~AyPh
H Cl
(94)
identified from its spectroscopic properties and by comparison with
an authentic sample prepared from N-t-butylamine and a-chlorophenyl-
acetyl chloride. The same product was also obtained from the reaction,
in benzene, between N-t-butylhydroxylamine and two equivalents each of
phenylacetyl chloride and pyridine. The mechanism of formation of
the a-chloro-amide from the hydroxylamines (Scheme XVIII) involves
an a-lactam intermediate. Attack by chloride ion at the a-carbon of
(63) leads to the observed amide (94).
The hydroxamic acid (93) was eventually obtained from N-t-butyl-
hydroxylamine in a one-pot synthesis (Schp.me XIX) as follows.
N-t-Butylhydroxylamine (90) was converted into the o-trimethylsilyl
ether (96) by treatment with trimethylchlorosilane and triethylamine
in methylene chloride. Addition of phenyl acetyl chloride and triethyl-
amine gave, presumably~ the hydroxylamine (97) which was hydrolysed
with dilute hydrochloric acid to give the hydroxamic acid (93) in
32% overall yield. The only data reported by Perkins and his co-workers
for (93) was a melting point of 8S-86°C and this disagreed with the
melting point (129-l30°C) presently found for this compound.
The bisphenylacetylhydroxylamine (95) was postulated as an inter-
mediate in the reaction between N-t-butyl hydroxyl amine and phenyl acetyl
71
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(90 ) (96) (97)
o
-7-,~Ph
OH
(93)
SCHEME XIX Reagents: i, TMSC1-NEt3-CH2C12; ii, PhCH2COC1-NEt3-CH2C12;
iii, di1. HCl.
chloride. This compound was prepared from the hydroxamic acid (93) by
treatment with phenylacetyl chloride but all attempts (see Experimental)
to convert it into the ~-chloro-amide (94) failed and starting material
was recovered.
Reaction of N-t-butylphenylacetohydroxamic acid (93) with
toluene-p-sulphonyl chloride in methylene chloride containing triethyl-
amine afforded the ~-chloro-amide (94) (29%) and not the desired
tosylate (98). The mechanism followed a similar pathway to that depicted
o
-7-~~h
OTs
(98)
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in Scheme XVIII. Indirect evidence for the formation of an a-lactam
intermediate was obtained by recording the i .r. spectrum of the
reaction mixture at various intervals. Thus, a carbonyl band at 1850 cm-1
appeared and grew in intensity as the a-lactam was generated, and then
diminished and finally disappeared as the chloride ion cleaved the
ring to yield the a-chloro-amide (94). It was clear that the rate of
formation of the chloro-amide was comparable to that of the a-lactam.
It was noted earlier that l-t-butyl-3-phenylaziridin-2-one, the
intermediate proposed in the above reaction, was the first a-lactam
to be isolated. The two literature preparations49,so of this compound
were attempted but, although in each case the a-lactam was formed
(carbonyl absorption at 1 850 cm-1 in the i.r. spectrum), it could
not be separated (fractional crystallisation) from the starting
material.
As a result of these failures a synthesis of the a-lactam (63)
from the hydroxamic acid (93) was developed in the following way.
Trifluoromethanesulphonic (triflic) anhydride ;s a reagent used to
form sulphonate esters (triflates),69 which are similar to tosylates.
However the triflate anion is a weaker nuc1eophi1e than the tosy1ate
or chloride anions. In addition, the trif1ate group is much more
reactive towards displacement than the corresponding tosy1ate group.
Accordingly, triflic anhydride (1.2 mol equiv.) was added to a solution
of N-t-buty1phenylacetohydroxamic acid (1 mol equiv.) and triethylamine
(2.2 mol equiv.) in dry methylene chloride at -70°C and afforded, after
careful work-up (see Experimental), the ~-lactam (63) as a low melting
crystalline solid in 97% yield.
With tetrabuty1ammonium chloride as a chloride ion source in
methylene chloride the a-lactam (63) gave the a-chloro-amide (94) in
53% yield. This result supports the idea that 1-t-butyl-3-phenylaziridin-
2-one was an intermediate in the aforementioned aliphatic reactions and,
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this in turn, gave support to the mechanisms envisaged for the novel
reactions discussed in Section 4.1.
In order to investigate whether the hydroxamic acid route to
a-lactams was generally valid, the synthesis, by the above method of
1,3-di-t-butylaziridin-2-one (99) was undertaken. This compound (99)
is the most stable a-lactam known and is normally prepared by the
cyclisation of the a-bromo-amide (100) with potassium t-butoxide.52
Thus, N-t-butyl-(3,3-dimethylbutano)hydroxamic acid (101) was obtained
from N-t-butylhydroxylamine by a similar procedure to that used for
~r
H Br
(100) (99) (101)
the preparation of (93). However, this hydroxamic acid could not be
converted into the a-lactam (99) by treatment with triflic anhydride
and triethylamine. The reaction was repeated using l,S-diazobicyclo-
[4.3.0]non-S-ene and again using lithium diisopropylamide in place of
triethylamine (see Experimental) but no a-lactam was formed in either
experiment, presumably because the methylene protons in the hydroxamic
acid were not sufficiently acidic to be removed rapidly by these bases.
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CHAPTER 5
1,2-0XAZETIDIN-3-0NES
All the work on a-lactams described in Chapter 4 stemmed from
the reaction between the cycloadduct (53; R = C02But) and sodium
ethoxide. It was also noted that the analogous treatment of the
hydroxamic acid (56) led to the l4-aminocodeinone derivative (68).-
NC02But
N(OH)COCH2Cl
MeO
(56 ) (68)
The structure of the amine (68) was based on spectroscopic data.
In particular, the mass spectrum and elemental analysis established
the molecular formula C24H30N206' The presence of a primary amine
group was suggested by the two-proton exchangeable signal at 01.85
in the IH n.m.r. spectrum and the absorptions at 3 390 and 3 320 cm-1
in the i .r. spectrum. The structure of (68) was confirmed by its
conversion, with acetic anhydride and pyridine, into the amide (102)
and to the known amine17 (103), isolated as the dihydroch10ride, by
treatment with acid.
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(102 ) (103)
The mechanism of formation of (68) remains obscure. A
tentative proposal (Scheme XX) involves an oxazetidinone intermediate
(104) resulting from ring closure of the a-chlorohydroxamic acid.
Ring cleavage of (104), envisaged as base abstraction of a proton
at C-4, gives the glyoxalamide (105). An intramolecular hydride
migration followed by cleavage of the resulting carbinolamine yields
the final product (68).
Since the conversion of (56) into (68) was quite unexpected,
further experiments were carried out to clarify the reactions of
1,2-oxazetidin-3-ones with base. A few stable 1,2-oxazetidin-3-ones
have been reported in the literature. The first compound of this type
2,4,4-triphenyl-l,2-oxazetidin-3-one (106) was isolated in 1911 by
Staudinger and Jelagin70 by the cycloaddition of diphenyl ketene to
nitrosobenzene :
+
o
IIc
II -
C
Ph/ 'Ph
Ph"~-r
O-+Ph
Ph
(106 )
~
/ o
N~Cl
IOH
NaOEt
--+
(56 )
(105 )
1
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This method has been used more recently to prepare other 2,4,4-triaryl
derivatives.71 The main disadvantage of this route was caused by the
competing cycloaddition leading to the unstable 1,2-oxazetidin-4-ones.
A more satisfactory synthesis of N-substituted 4,4-diphenyl-l ,2-
oxazetidin-3-ones72 (108) was found to be via ring closure of
a-chlorohydroxamic acids (Scheme XXI). The hydroxamic acids (107;
R = alkyl, aryl), formed from N-substituted hydroxylamines and chloro-
diphenylacetyl chloride, were not isolated but underwent internal
displacement of the chlorine atom by the hydroxylamine oxygen to give
the oxazetidinones directly.
RNHOH R~N-;:OI .
HO 1
Ph Ph
R,~~
0----1--Ph
Ph
Ph2CCOC1
ICl
(107) (108)
SCHEME XXI
During the course of earlier work it was found that treatment
of the thebaine cycloadduct (59) with anhydrous hydrogen chloride in
ethylene glycol followed by basification with sodium hydrogen carbonate
and extraction gave a quaternary ammonium chloride (see Chapter 3).
The open-chain hydroxamic acid (109) was presumably formed first but it
was not isolated.
The experiment was repeated but, in the hope that the hydroxamic
acid (109) would be converted into the 14a-aminocodeinone (110), the
crude reaction mixture was treated with sodium methoxide solution. However,
the only product isolated (29%) was the methyl ester (111). The mass
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MeO
Me
N(OH)COCH2Cl
(59) (109 )
MeO
NMe NMe 0
N/O;_).l
I OMe
H
(11 0) (111 )
spectrum gave a molecular ion at m/z 444.1899 (C23H2SN207) with
fragments at m/z 413.1698 and 355.1653 corresponding to losses of OMe
and OCH2C02Me. The i .r. spectrum showed an ester carbonyl absorption
at 1 750 cm-1 and the IH n.m.r. spectrum showed a singlet at 03.77
due to the methoxy carbonyl protons and AB doublets at 04.14 and 4.44
attributed to the OCH2CO protons.
The mechanism suggested (Scheme XXII) for the formation of the
ester (111) from the hydroxamic acid (109) involved the generation of an
oxazetidinone intermediate (112). Attack by methoxide at C-3 of (112)
followed by cleavage of the amide bond (N-C-3) gave the product (111).
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tThus, the change of NC02Bu to NMe in the alkaloid nucleus was
sufficient to alter the reaction course.
o
N).l__ Cl
I
HO
(109) (112 )
/
o
N/O~OMe
I
H
(111 )
SCHEME XXII
Analogous studies with a model ~-chlorohydroxamic acid also
yielded ester products (Scheme XXIII). a-Ch1oro-N-t-butylaceto-
hydroxamic acid· (113) was prepared from N-t-buty1hydroxylamine using
the one-pot procedure. The hydroxamic acid (113) was treated with
sodium methoxide in methanol at room temperature for 2 h. Dilute
hydrochloric acid was added, the solvent evaporated in vacuo, and
extraction of the resulting residue afforded the methyl ester hydro-
chloride (l14a) in 62% yield. The reaction was repeated in methanol-d4
in an n.m.r. tube. Figure 7 is a schematic representation of the
changes which took place in the IH n.m.r. spectrum as sodium deuterio-
methox;de was added. Spectrum b, recorded after the addition of
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0.75 mol equiv. of base, showed signals corresponding to the
starting material (01.41) and the product (01.07 and 4.27). The
transitory signals at 01.35 and 4.41 were attributed to the inter-
mediate. The origin of the extra peak at 05.14 remains obscure.
Further addition of base caused a small peak at 01.12 to appear in
the spectrum but it was not established whether this was due to the
t-butyl protons of t-butylamine, the other conceivable product.
Treatment of the hydroxamic acid (113) with sodium ethoxide
followed by a similar work-up to the above gave a 72% yield of the
ethyl ester hydrochloride (l14b). A satisfactory elemental analysis
of this compound was not obtained and it was assumed that (l14b) was
slightly hygroscopic.
Thus it appears that the preferred mode of oxazetidinone ring
opening ;s by cleavage of the N-C-3 bond. The alternative pathway,
viz. cleavage of the N-O bond, suggested to account for the l4s-amino-
norcodeinone (68) may be a result of the bulky t-butoxycarbonyl group
in (56) preventing the approach of methoxide to C-3.
The later part of this mechanism (see Scheme XX) involves
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hydrolysis of a glyoxa1amide to an amine. In order to investigate
this process further, the synthesis (Scheme XXIV) of the model
compound (117) was undertaken. The adamantylamide (116) was prepared
in 72% yield from 1-aminoadamantane (115) and ethyl diethoxyacetate.
o
Jl -OEt
HN/ "<OEt
H
(115 ) (116 )
IHCl
o
HN~O
H
(117)
SCHEME XXIV
An attempt to hydrolyse the diethy1 acetal of (116) with dilute
hydrochloric acid in methanol gave a low yield of a white powder.
The IH n.m.r. spectrum of this material showed a sharp singlet at
09.12 which integrated as less than one proton. The mass spectrum
indicated that the white powder was in fact a mixture of the
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glyoxa1amide (117) (m/z 207.1256, C12H17N02) and the Schiff base
(118) (m/z 340.2512, C22H32N20). Thus it appeared that initially
the desired compound (117) was formed but it then reacted further
with the product of further hydrolysis, l-aminoadamantane, to give
the Schiff base.
o
N=~NH
(118 )
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CHAPTER 6
EXPERIMENTAL
Instrumentation and General Notes
Melting points were determined on a Reichert Kofler hot-stage
apparatus. I.r. spectra were recorded on either a Perkin-Elmer 580
or 257 spectrometer and u.v. spectra on a Pye-Unicam SP 8-100
spectrometer. lH n.m.r. spectra were recorded at 90 MHz on a Perkin-
Elmer R32 instrument and, where stated, at 250 MHz on a BrUcker
W.M. 250 instrument. 13C n.m.r. spectra were recorded at 25.2 MHz
on a Varian XL-lOa spectrometer; chemical shifts in both cases are
quoted as p.p.m. downfie1d from tetramethy1si1ane. Low resolution
mass spectra were recorded at 70 eVan an A.E.I. M.S. 12 instrument
and high resolution spectra on an A.E.!. M.S. 9 instrument coupled
to a GEC-90S computer for data capture and processing. Optical
rotations were recorded on an Optical Activity AA-lOO polarimeter.
Preparative plate chromatography was carried out on Merck GF254
silica with detection of compounds by u.v. light. Column
chromatography was carried out on Merck silica HF254 under reduced
pressure using the method of Targett et aZ.73 and on CAMAG M.F.C.
neutral alumina Brockmann activity 1. Organic solutions were dried
over anhydrous magnesium sulphate and evaporated on a rotary
evaporator at aa. 50°C at 15 mm Hg unless otherwise stated. Petroleum
ether refers to the fraction ti.p, 50-aO°C and ether' rl:!fersto diethyl
ether. Elemental analyses were carried out by the microanalytical
service, Chemistry Department, Glasgow.
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Dihydrothebaine~ (26). - The procedure of Bentley et aZ.23
using thebaine (6.22 g) and sodium (1.43 g) gave dihydrothebaine-~
(5.64 g, 90%). A sample was recrystallised from ethyl acetate -light
petroleum, m.p. 151-153°C (lit.,23 154°C).
Dihydrothebaine~ 4-PhenyZ Ether (30). - The procedure of Sawa
et aZ.27 was followed and afforded, from dihydrothebaine-~ (3.13 g)
and bromobenzene (3.12 g), dihydrothebaine-~ 4-phenyl ether which
crystallised from isopropanol (2.15 g, 55%), m.p. 137-l38°C (lit.,27
135-l36°C) .
Deoxydihydrothebaine~ (28). - The procedure of Sawa et aZ.27
using dihydrothebaine-~ 4-phenyl ether (1.01 g) and sodium (0.18 g)
gave deoxydihydrothebaine-~ (0.61 g, 88%) as an oil.
S-Dihydrothebaine (27). - Sodium (4.51 g, 196 mmol) and a few
crystals of hydrated ferric nitrate were added with stirring to dry
liquid ammonia (aa. 250 ml). After aa. 30 min sodamide had formed.
Thebaine (20.1 g, 64.6 mmol) was added followed by sodium (4.51 g,
196 mmol) and the mixture was stirred for 3 h at -33°C. After
evaporation of the liquid ammonia, ethanol (25 ml) and water (275 ml)
were added and the mixture filtered. Addition of solid carbon
dioxide to the filtrate precipitated the products which were extracted
into chloroform (4 x 100 ml). The combined extracts were washed with
water, dried, and evaporated. The resultant brown oil was filtered
through an alumina column [200 g, methanol-chloroform (1:19)].
Fractional crystallisation of the concentrated eluate from light
petroleum-ethyl acetate yielded B-dihydrothebaine (8.56 g, 42%).
N.m.r. spectroscopy showed this to be contaminated with dihydro-
thebaine-~ (ca. 20%).
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B-DihydPothebaine 4-Phenyt Ether (31). - 8-0ihydrothebaine
(6.19 g, 20 mmol), bromobenzene (6.38 g, 40 mmol), finely powdered
anhydrous potassium carbonate (4.34 g, 31 mmol), and precipitated
copper metal (0.64 g, 10 mmo1) were refluxed with stirring in dry
pyridine (lOa ml) for 6 h. The mixture was filtered while still hot
and the residue washed with hot pyridine. The filtrate was evaporated
and the res idua 1 pyri dine removed by azeotropi n9 wi th tol uene
(4 xaa. 20 m1). The residue was dissolved in benzene, filtered, washed
with water, dried, and evaporated. The resultant brown gum was
purified by column chromatography on alumina (150 g) with methanol-
chloroform (1:49) as eluant to afford B-dihydrothebaine 4-phenyt ether
(4.48 g, 58%) as a dark viscous oil (Found: M+, 389.1982. C2sH27N03
requires M, 389.1991); o(CDC13) 2.33{3H,s,NMe), 3.47 (3H, s, 6-0Me),
3.S9 (3H, s, 3-0Me), 4.79 (lH, brd, JS-H 7 Hz, 7-H), 5.76 (lH, d,
J7-H 7 Hz, 8-H), and 6.65-7.40 (7H, m, aryl-H).
Attempted Reduation of B-Dihydrothebaine 4-Pheny"l Ether (31)
with Sodium in Liquid Ammonia. - A solution of B-dihydrothebaine
4-phenyl ether (150 mg, 0.39 mmol) in toluene (1.5 ml) was added to
dry liquid ammonia (aa. 25 ml) at -SOOto -S5°C. Sodium (45 mg, 2 mrnol)
was added and the solution went orange. After stirring for 1 h a
small amount of ammonium chloride was added to the mixture, the liquid
ammonia was evaporated and water (10 ml) was added. The solution was
extracted wi th ether (2 x 10 ml) and the co!1iJined extracts were washed
with S% sodium hydroxide solution (2x10 ml) and water (la ml), dried,
and evaporated to yield a yellow oil (i9 mg). T.1 .c. on silica
[methanol-chloroform (1:1)] indicated that several products had formed.
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Attempted Ieomez-ieatrionof Deoxydihydrothebaine~ (28) with
DichZoromaZeic Anhydride. - Deoxydihydrothebaine-~ (110 mg, 0.37 mmol)
and dichloromaleic anhydride30 (la mg, 0.06 mmol) were refluxed in
toluene (la ml) for 2 h. After cooling, ether (20 ml) was added and
the solution washed with 5% sodium hydroxide solution (2 x 10 ml) and
water (10 m1), dried, and evaporated to yield unreacted starting
material (90 mg), identified by n.m.r. spectroscopy.
Attempted Isomerisation of Deoxydihydrothebaine-~ (28) with
Sodamide. - Deoxydihydrothebaine-~ (199 mg, 0.67 mmol) in toluene (2 m1)
was added to sodamide [prepared from sodium (75 mg, 3.2 mmol)] in dry
liquid ammonia (ca. 50 ml). After stirring for 90 min at -33°C the
liquid ammonia was evaporated and water (30 ml) added. The solution
was extracted wi th ether (2 x 30 m1) and the cOnDi ned extracts were
washed with 5% sodium hydroxide solution (2x30 ml) and water (30 ml),
dried, and evaporated to give a yellow oil (128 mg). N.m.r. spectro-
scopy suggested that isomerisation could have occurred.
Attempted Trapping of the Sodamide Isomerisation Product with
NitrosocarbonyZbenzene. - The foregoing isomerisation product (128 mg) in
ethyl acetate (10 ml) and sodium periodate (138 mg, 0.65 mmo1) in
aqueous sodium acetate (0.2M, adjusted to pH 6 with concentrated
hydrochloric acid) (5 ml) were stirred rapidly at aoc. Benzohydroxam;c
acid41 (90 mg, 0.66 mmol) was added slowly over 10 min, then rapid
stirring was continued for 2 h. The mixture was basified with aqueous
sodium hydrogen carbonate and the layers separated. The aqueous
layer was extracted with ethyl acetate (2 x 10 m1) and the combined
ethyl acetate layers were washed with aqueous sodium thiosulphate
(2 x 10 ml) and water (10 m1), dried, and evaporated to a yellow gum
(186 mg). T.l.c. on silica [methanol-chloroform (1:9)] and n.m.r.
examination of the residue indicated that several products had been
formed, none of which was identified.
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613"14 e.-(N-3-Phenylpropanoylepoxyirrrino)-5" 6"14-O-tetrahydro-
thebaine Phenyl Ether (33; R = CH2CH2Ph). - S-Oihydrothebaine 4-phenyl
ether (1.95 g, 5 mmol) in ethyl acetate (100 ml) and sodium periodate
(1.61 g, 7.5 mmol) in aqueous sodium acetate (O.2M, adjusted to pH 6
with concentrated hydrochloric acid) (50 ml) were rapidly stirred at
o C. Dihydrocinnamohydroxamic acid4I (1.24 g, 7.5 mmol) in ethyl
acetate (5 ml) was added slowly over 10 min. then rapid stirring
was continued for 1 h. The mixture was basified with aqueous sodium
hydrogen carbonate and the layers separated. The aqueous layer was
extracted with ethyl acetate (2 x 50 ml) and the combined ethyl
acetate layers were washed with 5% aqueous sodium thiosulphate (2 x 50 ml)
and water (50 ml). dried, and evaporated to yield the ayaZoadduat
(33; R = CH2CH2Ph) which crystallised as granules from ethyl acetate
(1.30 g, 47%), m.p. 136-l38°C (Found: C, 73.70; H, 6.76; N, 4.98;
M+,522. C34H36N20S requires C, 73.89; H, 6.57; N, 5.07%; M, 522);
vrnax(KBr) 1 685 cm-I; o(CDC13) 2.39 (3H, s, NMe), 3.28 (3H, s, 6-0Me),
3.63 (3H, s, 3-0Me), 4.55 (lH. m, 9-H), 6.21 (lH, d , Ja-H 7 HZ, 7-H),
and 6.65-7.40 (13H, m, aryl-H and 8-H).
EtfqJlene Acetal: of 14 S-(N-3 -Phenylpl'Opanoylhydroxyarrrino) thebainone
Phenyl Ether (34; R = CH2CH2Ph). - The cycloadduct (33; R = CH2CH2Ph)
(552 mg, 1 mmo1) in dry methylene chloride (5 ml) was treated with
anhydrous hydrogen chloride in ethylene glycol (0.3M; 15 ml). The
reaction mixture was stirred at room temperature for 90 min, then
basified with solid sodium hydrogen carbonate followed by saturated
sodium hydrogen carbonate solution and water. The mixture was extracted
with chloroform (4 x 10 m1) and the combined extracts were washed with
brine (2 x 10 ml) and water, dried, and evaporated. The resulting oily
solid consisted of the thebainone ethylene acetal and the thebainone
(35; R = CH2CH2Ph, af. p.90). The thebainone was precipitated by the
addition of ethyl acetate and filtered off (255 mg, 42%). The filtrate
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yielded the ethylene acetal (34; R = CH2CH2Ph) (270 mg, 46%) as a
foam (Found: M+, 582.2720. C3sH3SN206 requires M, 582.2730); vmax
3 290 and 1 655 em-I; c(CDC13) 2.36 (3H, s, NMe), 3.64 (3H, s, OMe),
3.55-4.05 (4H, m, OCH2CH20), 4.15 (lH, m, 9-H}, 5.74 (lH, d, Js-H 10 Hz,
7-H), 6.65-7.45 (13H, m, aryl-H and 8-H), and 7.55 (lH, br s, OH).
Ethylene Acetal of 14 S-(3 -Phenylpropanoylamino) thebainone Phenyl
Ether (35; R = CH2CH2Ph). - The ethylene acetal (34; R = CH2CH2Ph)
(378 mg, 0.65 mmol) was dissolved in dry pyridine (10 ml). Dry
sulphur dioxide was slowly bubbled through the solution for 30 min
and then the solution was heated under reflux for 1 h. The mixture
was cooled, diluted with sodium hydrogen carbonate solution and
extracted wi th ch1oro form (4 x 10 ml). The combi ned extracts were
dried and evaporated and the residual pyridine removed by azeotroping
with toluene (4x). The residue was chromatographed on silica plates
[methanol-chloroform (1:9)] to afford the ethylene acetal (35;
+R = CH2CH2Ph) (RF 0.60) (112 mg, 30%) as a foam (Found: M , 566.2775.
C33H3SN20S requires M, 566.2781); vmax(KBr) 1 670 cm-I; o(CDC13)
2.30 (3H, s, NMe), 3.65 (3H, s, OMe), 3.84 (4H, m, OCH2CH20), 5.52
(lH, br s, NH), 5.14 (lH, d, Js-H 11 Hz, 7-H), and 6.55-7.40 (13H,
m, ary1-H and 8-H).
Attempted Reduction of Ethylene Acetal (35; R = CH2CH2Ph) with
Lithium Aluminium Hydride. - The foregoing ethylene acetal (35;
R = CH2CH2Ph) (83 mg, 0.15 mmo1) in dry tetrahydrofuran (THF) (2 m1)
was slowly added to lithium aluminium hydride (35 mg, 0.92 mmol) in
dry THF (5 ml) under nitrogen. After being refluxed for 1 h the
reaction mixture was cooled and quenched by the cautious dropwise
addition of water and sodium hydroxide solution. Excess water was
removed with anhydrous magnesium sulphate and the mixture was filtered
through ce11ite and evaporated. The i .r. spectrum of the residue indicated
that starting material was present.
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14B-(N-3-PhenyLpropanoyLhydroxyamino)thebainone PhenyL Ether (36). -
The cyc loadduct (33; R = CH2CH2Ph) (55 mg, 0.1 rrmol) in methanol (5 ml)
containing 5M hydrochloric acid (3 ml) was heated at 60°C for 30 min.
The mixture was basified with sodium hydroxide solution and extracted
wi th ch 1orofonn (4 x 3 m1). The comb ined extracts were washed wi th
water (3 m1), dried, and evaporated to yield the thebainone (36) which
crystallised from ethanol as cuboids (24 mg, 45%), m.p. 241-242.SoC
+(Found: C, 73.46; H, 6.13; N, 5.30; M ,538.2464. C~3H34N205 requires
C, 73.58; H, 6.36, N, 5.20%; M, 538.2468); vmax{KBr) 3 280, 1 670 (sh),
and 1 655 cm-1; o[(CD3)ZSO] 2.26 (3H, s, NMe), 3.54 (3H, s, OMe),
3.86 (lH, m, 9-H), 5.84 (lH, d, Js-H 9 Hz, 7-H), 6.70 (lH, d, J7-H 9 Hz,
8-H), 6.85-7.45 (12H, m, aryl-H), and 9.32 (lH, br s, exchangeable with
D 20, OH).
l4S-(3-PnenylpropanoyLamino)thebainone Phenyl Ether (37). - The
thebainone (36) (190 mg, 0.35 ml) was dissolved in dry pyridine (10 m1).
Dry sulphur dioxide was slowly bubbled through the solution for
30 min and then the solution was heated under reflux for 90 min. The
mixture was cooled, diluted with sodium hydrogen carbonate solution,
extracted wi th ch1oroforrn (4 x 5 m1), and the extracts were dried and
evaporated. The residue was filtered through an alumina column (10 g)
with chloroform as eluant to yield the thebainone (37) which crystallised
from ethyl acetate as fine needles (113 mg, 61%), m.p. 223-224°C (Found:
+C, 75.60; H, 6.37; N, 5.44; M ,522. C33H34NZ04 requires C, 75.84;
H, 6.56; N, 5.36%; M, 522); vmax(KBr) 1 670 cm-1; o(CDC13) 2.34
(3H, s, NMe), 3.67 (3H, s, OMe), 5.67 (lH, br s, NH), 6.0Q (lH, d,
Js-H 10 Hz, 7-H),6.60-7.40 (12H, rn, aryl-H), and 7.55 (lH, d, J7_H
10Hz, 8-H).
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S-DihydPothebaine 4-(1-PhenyZtetra2oZ-5-yZ) Ether (39). - S-Oihydro-
thebaine (3.13 g, 10 mmol), 5-ch1oro-1-pheny1tetrazo1e (3.61 g, 20 mmo1),
and finely ground anhydrous potassium carbonate (5.52 g, 40 mmo1) in
anhydrous acetone (50 m1) were refluxed with stirring for 4 days. After
cooling, the solution was filtered and evaporated and the residue
chromatographed on silica (145 g) under reduced pressure. The fractions
eluted with 0-5% methanol-chloroform contained excess reagent. The
fractions eluted with 10% methanol-chloroform afforded the phenyZ-
tetra20ZyZ ether (39) (2.63 g, 5B%) as a pale yellow foam (Found:
M+, 457.2101. CZ6H27Ns03 requires M, 457.2114); o(CDC13) 2.39 (3H, s,
NMe), 3.47 (3H, s , 6-0Me), 3.64 (3H, s, 3-0Me), 4.83 (lHt br d ,
JS-H 6 Hz, 7-H), 5.82 (lH, d, J7-H 6 Hz, 8-H), 6..82 (lH, d, Jz-H 9 HZt
l-H), 7.04 (lH, d, JI-H 9 Hz, 2-H), and 7.40-8.00 (5H, m, Ph).
6e,14s-(N-3-PhenyZpropanoyZepoxyimino)-5,6, 14,0-tetrahydrothebaine
l-PhenyZtetra2oZ-5-yZ Ether (40). - The S-dihydrothebaine (39) (1.144 g,
2.5 mmo1) in ethyl acetate (50 m1) and sodium periodate (0.803 g,
3.75 mmo1) in aqueous sodium acetate (0.2M, adjusted to pH 6 with
concentrated hydrochloric acid) (30 ml) were stirred rapidly at O°C.
Oihydrocinnamohydroxamic acid (0.619 g, 3.75 mmo1) in ethyl acetate
(6 ml) was added slowly over 12 min, then rapid stirring was continued
for 1 h. The mixture was basified with aqueous sodium hydrogen
carbonate and the layers separated. The aqueous layer was extracted
w;th ethyl acetate (2 x 25 m1) and the comb; ned ethyl acetate 1ayers were
washed with 5% aqueous sodium thiosulphate (2 x 25 m1) and water (25 m1),
dried, and evaporated to yield theayaZoadduat (40) which crystallised
from ethanol as fine needles (0.717 9, 46%), m.p. lB5-l86.5°C (Found:
+C, 67.90; H, 5.B5; N, 13.44; M ,620.2746. C3sH36N60S requires C, 67.72;
H, 5.86; N, 13.54%; M, 620.2747); vmax(KBr) 1 685 cm-I; 6(CDC13) 2.40
(3H, s, NMe), 3.37 (3H, s, 6-0Me), 3.63 (3H, s, 3-0Me), 4.56 (lH, m, 9-H),
6.23 (lH, d, Ja-H 8 Hz, 7-H), and 6.75-7.95 (13H, m, aryl-H and B-H).
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l4B-(N-3-PhenylpropanoyZhydroxyamino)thebainone l-PhenyZtetrazol-
5-yl Ether (41). - The cycloadduct (40) (192 mg, 0.31 mmol) in methanol
(25 ml) containing 5M hydrochloric acid (15 m1) was heated at 60°C
for 30 min. The residue was basified with sodium hydroxide solution
and extracted with chloroform (4x 10 ml). The combined extracts were
washed with water, dried, and evaporated. The residue was chromato-
graphed on silica plates [methanol-chloroform (1:9)] to afford the
+thebainone (41) (Rf 0.66) (96 mg, 51%) as a foam (Found: M , 606.2626.
C34H34N60S requires M, 606.2590); vmax(KBr) 1 660 and 1 650 cm-I;
o(CDC13) 2.35 (3H, s, NMe), 3.66 (3H, s, OMe), 4.34 (lH, m, 9-H),
6.08 (lH, d, Ja_H 11 Hz, 7-H), and 6.80-7.95 (13H, m. aryl-H and 8-H).
14B-(3-PhenyZpropanoyZamino)thebainone l-PhenyZtetrazoZ-S-yZ
Ether (42). - The thebainone (41) (150 mg, 0.25 mmol) was dissolved in
dry pyridine (10 ml). Dry sulphur dioxide was slowly bubbled through
the solution for 30 min and then the solution was heated under reflux
for 90 min. The mixture was cooled, diluted with sodium hydrogen
carbonate solution, extracted with chloroform (4 x 5 ml), and the extracts
were dried and evaporated. The residue was chromatographed on silica
plates to give the thebainone (42) (Rf 0.64) (74 mg, 51%) as a foam
(Found: M+, 590.2612. C34H34N604 requires M, 590.2641); vmax(KBr) 1 665
and1650 (sh) cm-I; o(CDC13) 2.30 (3H, s, NMe), 3.62 (3H, s, OMe).
3.78 (lH, brd,J1oa_H 6 Hz. 9-H). 5.94 (lH, d, Ja-H 10 Hz, 7-H),
6.20 (lH, br s, NH), and 6.80-7.90 (13H, m, aryl-H and 8-H).
Attempted hydPogenolyses of the PhenyltetrazolyZ Ethers.- Attempts
were made to carry out hydrogenolysis of the cycloddduct (40j and the
thebainones (41) and (42). The experiments done are outlined in Table 7.
Each experiment yielded only starting material which was identified by
its n.m.r. spectrum.
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TABLE 7
Expt. Cmpd. No. Solvent Ca ta1ys t Pressure
A 40 ethano1-THF (1 :1) 5% Pd-C atmospheric
B 40 ethyl acetate 5% Pd-C atmos phe ric
C 41 ethyl acetate 5% Pd-C atmospheri c
D 42 ethyl acetate 5% Pd-C atmospheric
E 42 ethyl acetate 10% Pd-C atmospheric
F 42 ethanol 10% Pd-C lOa tmos phe res
In experiments A, E, and F the weight of catalyst used was equivalent
to one-tenth that of the starting material and in experiments B, C,
and D two to four times this amount was used. The general procedure
is demonstrated in the following example (experiment F). The thebainone
(42) (85 mg, 0.14 mmo1) in dry ethanol (8 ml) was hydrogenated at
la atm. for 4.5 h with 10% palladium-charcoal catalyst (8.5 mg). The
mixture was filtered through cellite and the filtrate concentrated.
Northebaine HydroahLoride. - The procedure of R.I. Gour1ay,14 a
modification of the method of E. Lilley and CO.39 was followed. Thus,
thebaine (15.5 g, 50 1TIl)01)and ethyl azodicarboxy1ate (9.57 g, 55 mmol)
were heated under reflux in benzene (100 ml) for 3 h. The solvent was
evaporated to yield the intermediate N-(l ,2-diethoxycarbonylhydraz;no-
methyl)northebaine as an oil. This material was dissolved in ethanol
(100 ml), water (75 ml), and ammonium hydroxide (sp. g. 0.88,50 ml)
and heated under reflux for 5 h, then left at room temperature overnight.
The sol ution was extracted wi th methyl ene ch1oride (4 x 50 m1) and the
extracts were dried and evaporated to yield a brown oil. This oil was
dissolved in refluxing ethyl acetate (lOa ml) and, on cooling, the by-
product urethane precipitated which was removed by filtration. The
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filtrate was evaporated and the residue'dissolved in methanol and
treated with 10% methanolic hydrogen chloride (22 ml) until the
solution was just acidic. Northebaine hydrochloride precipitated
from the solution (9.80 g, 59%). A sample was recrystallised from
wa ter, m.p. 269-271 °C (decamp.) [1;t. ,39 270-272 °C (decamp.)].
N-EthoxycarbonyZmethyZnorthebaine (50). - Northebaine (0.684 g,
2.3 mmol), ethyl chloroacetate (0.27 ml, 2.5 mmol), and finely ground
anhydrous potassium carbonate (1.273 g, 9.2 mmol) were heated under
reflux in acetone (20 ml) for 20 h. The mixture was cooled and
filtered and the filtrate evaporated. The residue was chromatographed
on a column of alumina [15 g, toluene-chloroform (1 :1)] to afford
N-ethoxycarbonyZmethytnorthebaine (0.682 g, 77%) as an oil (Found:
+M ,383.1738. C22~25N05 requires M, 383.1733); vmax(CHC13) 1 745 cm-I;
0(COC13) 1.24 (3H, t, JCH 7 Hz, CH3), 3.40 (2H, s, CH2CO), 3.56 (3H,2
s, 6-or~e), 3.82 (3H, s, 3-0Me), 4.19 (2H, q, JCH 7Hz, CH2CH3), 5.00
3
(lH, d, Ja-H 7 Hz, 7-H), 5.24 (1H, s, s-a), 5.53 (1H, d, J7-H 7Hz,8-H),
6.55 (lH, d'~_H 8 Hz, l-H), and 6.66 (lH, d, JI-H 8 Hz, 2-H).
N-HydroxyaminocarbonyZmethyZnorthebaine (51). - Sodium hydroxide
solution (10M, 0.17 ml, 1.7 mmol) was added to a stirred solution of
hydroxylamine hydrochloride (59 mg, 0.85 rnmol) in water (0.5 ml) and
ethanol (0.5 ml) at DoC. The solution was warmed to room temperature,
N-ethoxycarbonylmethylnorthebaine (172 mg, 0.45 mmol) in ethanol (0.5 ml)
was added dropwise and the solution was stirred for a further 2.5 h.
The reaction mixture was acidified to pH 5.8 with 5% hydrochloric acid
and the solvent was evaporated. The residue was treated with water,
extracted with chloroform (4 x 5 ml) and the combined extracts were
dried and evaporated. The residue was chromatographed on silica plates
[methanol-chloroform (1:9)] to yield N-hydroxyaminocarbonyZmethyZnorthebaine
(59 mg. 36%) as a foam (Found: M+, 370.1546. CzoH22NzOs requires
M, 370.1529); vmax (CHC13) 3 385 and 1675 cm-I; o(COC13) 3.60 (3H, s, 6-0Me),
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3.84 (3H, s, 3-0Me), 5.02 (lH, d, JS-H 7 Hz, 7-H), 5.27 (lH, s, 5-H),
5.55 (lH, d, J7-H 7 Hz, 8-H), 6.18 (2H, br s, exchangeable with D20,
OH and NH), and 6.63 (2H, brs, l-H and 2-H).
Attempted Oxidative CyaLisation of N-HydroxyaminoaarbonyLmethyL-
northebaine to (52). - N-Hydroxyaminocarbony1methylnorthebaine (30 mg,
0.08 mmol) in ethyl acetate (0.5 ml) was added to a stirred solution of
sodium periodate (26 mg, 0.12 mmol) in aqueous sodium acetate (0.2M.
adjusted to pH 6 with concentrated hydrochloric acid) (1 ml) at DoC.
The cooling bath was removed, the mixture was stirred for 3 h and then
basified with aqueous sodium hydrogen carbonate. The layers were
separated, the aqueous layer was extracted with ethyl acetate (3 x 2 ml)
and the combined ethyl acetate layers were washed with 5% aqueous
sodium thiosulphate solution (2 x 2 m1) and water (2 m1), dried, and
evaporated. T.l.c. on silica indicated that six products had been
formed, two of which gave a positive "ferric chloride test.
HydroxyLamine.74,75 - To a stirring suspension of finely pulverised
hydroxylamine hydrochloride (17.84 g, 0.26 mmol) in anhydrous ethanol
(25 ml) was added sodium ethoxide solution [from sodium (5.76 g, 0.25 mmol)
in anhydrous ethanol (100 ml)] dropwise over 4 h. The solution was
rapidly filtered and the precipitate washed with a little ethanol. Ether
(aa. 15 ml) was added to the filtrate and the solution cooled to -78°C.
The precipitate hydroxylamine (4.72 g, 56%) was filtered onto a pre-
cooled (-78°C) funnel and used immediately.
~-ChLoroaaetohydroxamia Aaid.42 - Ethyl ch10roacetate (20 g, 0.16 mmol)
was dissolved in anhydrous ethanol (50 ml) and hydroxylamine (4.4 g, 0.13mmol)
was added. The solution was stirred at Doe for 0.5 h, then for3 h at
room temperature and finally left overnight in the refrigerator. ~-Ch10ro-
acetohydroxamic acid crystallised from the solution (7.10 g, 40%). A
specimen was recrystallised from ethyl acetate, m.p. 77-84°e (lit.,42
92-93°C); vrnax(KBr) 1 675 cm-I; o[(CD3)2S0] 3.95 (2H, s, CH2), and
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7.30 (7H, br s, exchangeable with 020); M+ 111 and 109.
N-t-Butoxyaapbonylnopthebaine43 (49; R = C02But). - Northebaine
(2.23 g, 7.5 mmol) was suspended in t-butanol (2.5 ml) and water (5 ml)
at room temperature with finely ground anhydrous potassium carbonate
(1.306 g, 7.5 mmol). Oi-t-butyl dicarbonate (1.08 g, 8.25 mmol) was
added slowly. The mixture was stirred for 1.5 h, diluted with water,
and extracted with methylene chloride (2x50 m1). The combined extracts
were washed with water, dried, and evaporated to give N-t-butyoxy-
carbonylnorthebaine which crystallised from methanol (2.41 g, 81%),
m.p. 174°C (lit.,43 16S-166°C); vmax(KBr) 1 690 cm-I; o(CDC13) 1.45
t(9H, s, Bu ), 3.61 (3H, s, 6-0Me), 3.86 (3H, s, 3-0Me), 5.03 (lH, d,
JS-H 7 Hz, 7-H), 5.29 (lH, s, 5-H), 5.59 (lH, d, J7-H 7 Hz, 8-H),
6.56 (lH, d, J2-H 8 Hz, 1-H), and 6.69 (lH, d, JI-H 8 Hz, 2-H).
6a,l4a-(N-ChloroaaetyZepoxyiminoJ-6, 14-dihydro-N-t-butoxyaarbonyZ-
nopthebaine (53; R = C02But). - N-t-Butoxycarbonylnorthebaine (0.990 9,
2.5 mmo1) and tetraethylammonium periodate44 (2.40 9, 7.5 mmol) were
stirred in chloroform (100 ml) at Oec. a-Ch1oroacetohydroxamic acid
(0.821 g, 7.5 mmol) in ethyl acetate (100 ml) was added slowly over
30 min, then stirring was continued for 1 h. The solution was washed
with 5% aqueous sodium thiosulphate (2 x 50 ml) and water (50 ml), dried,
and evaporated to yield the ayaZoadduat (53; R = C02But) (1.25 g, 99%)
which crystallised from chloroform-ethanol as rhomboids, m.p. l78-l79°C
+(Found: C, 59.32; H, 5.89; Cl, 7.38; N, 5.47; M , 506.1644, 504.1666.
C2sH29C1N207 requires C, 59.46; H, 5.79; Cl, 7.03; N, 5.55%; M, 506.1634,
504.1663); v (KBr) 1690 cm-I; o(CDC13) 1.48 (9H, s, But), 3.62 (3H, s,max
6-0Me), 3.82 (3H, s, 3-0Me), 3.98 and 4.18 (2H, d, d, ,T 15 Hz, CH2Cl),
4.61 (lH, s, 5-H), 6.08 (lH, d, Js-H 10 Hz, 7-H), 6.22 (lH, d, J7-H 10 Hz,
8-H), 6.57 (lH, d, J2-H 8 Hz, l-H),and 6.72 (lH, d, JI-H 8 Hz, 2-H).
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148-Hydroxyamino~-t-butoxycarbonylnoT'codeinone (54). - The
cycloadduet (53; R = C02But) (200 mg, 0.4 mmol) was dissolved in hot
ethanol and the solution diluted with water. The precipitate was
filtered off to give the noT'codeinone (54) (90 mg, 55%), m.p. 218-219°C
+(Found: C, 63.46; H, 6.04; N, 6.76; M ,414.1783. C22H26N206 requires
C3 63.75; H, 6.32; N, 6.76%; M, 414.1791); vmax(KBr) 3 320, 3 260, and
1680 cm-I; 0[(C03hSO] 1.41 (9H, s, But), 3.74 (3H, s , OMe), 4.62
(lH, br s, 5-H), 6.06 (lH, br s, exchangeable with 020, OH or NH),
6.07 (lH, d, JS_H 12 Hz, 7-H), 6.56 (lH, d, J7_H 12 Hz, 8-H), 6.64
(lH, d, J2-H 8 Hz, I-H), 6.79 (lH, d , JI-H 8 Hz, 2-H), and 7.71 (lH,
br s, exchangeable with 020, OH or NH).
58,14S-Epoxyimino-N-t-butoxycarbonylnoT'thebainone (55). - To a
stirred suspension of the noreodeinone (54) (100 mg, 0.24 mmol) in
anhydrous ethanol (2 ml) was added sodium ethoxide solution, prepared
from sodium (20 mg, 0.87 mmo1) in anhydrous ethanol (2 ml). Stirring
was continued for 10 min at room temperature and then the ethanol was
evaporated. The residue was dissolved in chloroform, washed with
brine (2 x 10 ml) and water (10 ml), dried, and evaporated. The crude
product was chromatographed on a silica plate [methanol-chloroform (1 :9)]
to yield the phenol (55) (Rf 0.56) (57 mg, 57%) as a foam (Found:
M+,414.1796. C22H26N206 requires 414.1791); vmax(CHC13) 3 540, 3 250,
and 1690 em-I; o(COC13) 1.45 (9H, s, But), 3.81 (3H, s, OMe), 4.92
(lH, br m, 9-H), 5.01 (lH, s, 5-H), 6.05 (lH, dd, JS-H 10 Hzv and JS-H
3 Hz, 7-H), 6 ..10 (2H, br s, exchangeable with 020, NH and OH), 6.65
(2H, s , I-H and 2-H), and 6.86 (lH, d, J7-H 10 Hz, 8-H).
148-(N-ChloT'OacetylhydroxyaminoJ-N-t-butoxycarbonylnoT'codeinone
Ethylene Acetal (56). - The cycloadduct (53; R = C02But) (1.251 g,
2.48 mmol) in methylene chloride (10 ml) was treated with anhydrous
hydrogen chloride in ethylene glycol (O.3M; 35 ml). The solution was
stirred at room temperature for 90 min, then basified with solid sodium
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hydrogen carbonate followed by saturated sodium hydrogen carbonate
solution and water. The mixture was extracted with chloroform
(4 x50 ml) and the extracts were dried and evaporated. The product
was chromatographed under reduced pressure on a silica column (25 g).
The fractions eluted with benzene-chloroform (1 :1) afforded the
ethylene acetal (56) as granules, (0.654 g, 49%), m.p. 198.5-199.5°C
(from ethanol) (Found: C, 58.54; H, 6.00; Cl, 6.56; N, 5.05; M+,
536.1741,534.1750. CZ6H3ICINzOa requires C, 58.36; H, 5.84; Cl, 6.64;
N, 5.24%; M, 536.1739,534.1769); vmax(CHC13) 3 245 and 1 685 cm-I;
o(CDC13) 1.42 (9H, 5, But), 3.85 (3H, s, OMe), 3.95-4.35 (6H, m, OCH2CH20
and CHzCl), 4.65 (lH, br s, 5-H), 5.70 (lH, br d, JS-H 10 Hz, 7-H),
6.32 (lH, br d, J7-H 10 Hz, 8-H), 6.54 (lH, d, J2-H 8 Hz, I-H), 6.70
(lH, d, JI-H 8 Hz, 2-H), and 8.50 (lH, s, exchangeable with D20, OH).
14e-Hydroxyamino-N-ahZoroacetylnorcodeinone Ethylene Acetal (58). -
The ethylene acetal (56) (1.27 g, 2.38 mmol) was dissolved in anhydrous -
ethyl acetate (20 ml). 10% Anhydrous ethyl acetate-hydrogen chloride
_ (20 ml) was added and the solution shaken for 15 min. The reaction
mixture was evaporated to dryness, the residue dissolved in chloroform
(15 ml), sodium hydrogen carbonate added and the mixture then shaken
for aa. 5 min. The inorganic material was filtered off and the filtrate
evaporated. The residue was chromatographed under reduced pressure on
a silica column (20 g). The fractions eluted with methanol-chloroform
(1:19) were crystallised from ethyl acetate to afford the ethylene acetaL
(58) as granules, (145 mg, 14%), m.p. 172-174°C (Found: C, 57.70; H, 5.34;
Cl, 8.18; N, 6.18; M+, 434.1267. CZIH23CiN206 requires C, 57.99; H, 5.33;
Cl, 8.16; N, 6.44%; M, 434.1244); vmax(CHC13) 3 575, 3 430, 3 300, and
1 630 cm-l; o(CDC13) 3.84 (3H, s, OMe), 4.19 (2H, s, CH2CO), 3.90-4.30
(4H, m, OCHzCHzO), 4.46 (lH, s, 5-H), 5.48 (lH, br rn, 9-H), 5.82 (lH, d
Ja-H 11 Hz, 7-H), 6.12 (lH, d, J7-H 11 Hz, 8-H), 6.58 (lH, d, J2-H 8 Hz,
I-H), and 6.72 (lH, d, Jl-H 8 Hz, 2-H).
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AZterrnative Prepara tzon of 74{3-Hlidroxya:mino-N~hZo1"oaC!et;lI 21101"-
codeinone Ethylene Acetal (58). - The cycloadduct (53; R = C02But)
(1 g, 2 mmol) in anhydrous methylene chloride (la mT) was treated
with anhydrous hydrogen chloride in ethylene glycol (0.3M; 35 ml). The
solution was stirred at room temperature for 90 min, then basified with
solid sodium hydrogen carbonate followed by saturated sodium hydrogen
carbonate solution and water. The mixture was extracted with chloroform
(4 x 50 ml) and the extracts were dried and evaporated to give the
ethylene acetal (58) which crystallised from ethyl acetate (0.321 g,
37%). The m.p. and the n.m.r. spectrum were identical to those obtained
in the above route.
6~ 14a-(N-Chlo~acetylepoxyimino)-6, 14~ihydrothebaine (59). -
Thebaine (1.55 g, 5 mmol) in ethyl acetate (75 m1) and sodium periodate
(3.21 g, 15 mmo1) in aqueous sodium acetate (0.2M, adjusted to pH 5.8
with concentrated hydrochloric acid) (50 m1) was stirred rapidly at O°C.
Cl-Chloroacetohydroxamic acid (1.65 g, 15 nmol) was added slowly over
10 min, then rapid stirring was continued for 1 h. The mixture was
basified with aqueous sodium hydrogen carbonate and the layers separated.
The aqueous 1ayer was extrac ted wi th ethyl aceta te (2 x 50 m1) and the
combined ethyl acetate layers were washed with 5% aqueous sodium thio-
sulphate (2 x 50 m1) and then water (50 ml). The dried ethyl acetate
so1ution was evapora ted to give the crude cycloadduot (59) (1.44 g, 69%)
as a foam (Found: [M - HC1]+, 382.1525, [M - MeCl]+, 368.1380.
C21H23C1N20S requires [M - HC1], 382.1529, [M - MeC1], 368.1372);
vmax(KBr) 1 695 cm-I; o(COC13) 2.44 (3H, s, NMe), 3.62 (3H, s, 6-0Me),
3.81 (3H, s, 3-0Me), 4:03 and 4.27 (2H, d,d, J 15 Hz, CH2C1), 4.61
(lH, br s , 5-H), 4.78 (lH, d, J1oa-H 8 Hz, 9-H), 6.11 (2H, br s, 7-H and
8-H), 6.58 (lH, d, J2-H 9 Hz, l-H), and 6.71 (lH, d , J1_H 9 Hz, 2-H).
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The Quaternary Ammonium Chloride (60). - The crude cycloadduct
(59) (168 mg, 0.4 mmol) was dissolved in ethyl acetate (2 ml) and
methanol (2 ml). Scratching induced precipitation of the quaternary
ammonium chZo~ide (60) which was recrystallised from methanol-ethyl
acetate (33 mg, 20%), m.p. 219-220°C (Found: C, 60.18; H, 5.38; Cl, 8.27;
N, 6.54; [M - HC1]+, 382.1532, [M -MeC1]+, 368.1352. CZIHz3C1NzOs
requires C, 60.21; H, 5.53; Cl, 8.47; N, 6.69%; [M - HC1], 382.1529,
[M - MeCl], 368.1372); vmax(KBr) 1 690 cm-I; o[(CD3)zSO] 3.30 (3H, s,
NMe), 3.47 (2H, s, CH2CO), 3.60 (3H, s, 6-0Me), 3.76 (3H, s, 3-0Me),
4.63 and 5.15 (2H, d,d, J 15 Hz, CH2CO), 4.91 (lH, br s, 5-H), 6.24
(lH, d , JS-H 9.Hz, 7-H), 6.70 (lH, d, J7-H 9 Hz, 8-H), 6.71 (lH, d ,
J2-H 8 Hz, 1-H), and 6.90 (lH, d, JI-H 8 Hz, 2-H).
The Quaternary Ammonium ChloPide (61). - The crude cycloadduct
(59) (184 mg, 0.44 mmol) in methylene chloride (1 ml) was treated with
anhydrous hydrogen chloride in ethylene glycol (0.3M; 5 ml). The
solution was stirred at room temperature for 90 min, then basified with
solid sodium hydrogen carbonate followed by saturated sodium hydrogen
carbonate solution and water. The mixture was extracted with methylene
chloride (4 x 5 ml) and the combined methylene chloride layers were washed
with brine (2 x 5 ml ) and water (5 ml), dried, and evaporated to a foam
which crystallised from methanol. Recrystallisation from methanol gave
the quaternary ammonium chZoride (61) as the hydrate (77 mg, 38%), m.p.
230-232°C (Found: C, 56.36; H, 5.91; Cl, 7.85; N, 5.62; [M-HCl]+ {-H20} ,
412.1627, [M-MeC1]+ {-H20} ,398.1496. C22H2SC1N206.HzOrequires C, 56.58;
H, 5.83; Cl, 7.60; N, 6.00%; [M - HC1]{-H20}, 412.1634. [M - MeCl] {~H20},
398.1478); vmax(KBr) 1 680 cm-I; o[(CD3)2S0] 3.33 (3H, s, NMe), 3.84
(3H, s, OMe), 3.94 (4H, br s, OCH2CH20), 4.82 (lH, s, 5-H), 5.74 (lH, d,
JS-H 9 HZ3 7-H), 5.90 (lH, d, J7-H 9 Hz, 8-H), 6.72 (lH, d, J2-H 8 Hz,
I-H), and 6.87 (lH, d , JI_H 8 Hz, 2-H).
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148-(2,2-Diethoxyethanoylamino rN-t-butoxycarbonytnorcodeinone (69). -
The cycloadduct (53; COzBut) (504 mg, 1 mmol) was dissolved in anhydrous
ethanol (10 ml) and sodium ethoxide solution added (8.44 ml, 4 mol equiv.)
[from sodium (108 mg, 4.7 mmol) in anhydrous ethanol (10 ml)]. After
stirring for 20 min at room temperature the solvent was evaporated and
water was added followed by solid carbon dioxide until pH 8. The
aqueous solution was extracted with chloroform (4 x 10 ml) and the extracts
were dried and evaporated. The residue was treated with a little ethyl
acetate whereupon the norcodeinone (69) separated and was recrystallised
from ethyl acetate as plates (104 mg, 20%), m.p. 205-206°C (Found:
C, 63.70; H, 6.95; N, 5.24; M+ 528.2484. CZSH36N20S requires C, 63.62,
H, 6.86; N, 5.30%; M, 528.2471); vmax(CHC13) 3 390, 3 340 (sh), and
1 695 cm-l; o(CDC13) 1 .20 (3H~ t, JCHz 7 Hz, CH2CH3), 1.24 (3H, t, JCH2
t7 Hz, CH2CH3), 1.47 (9H, s, Bu), 3.62 [4H, br dq, JCH3 7 Hz, C(CH2CH3}zL
3.85 (3H, s, OMe), 4.72 [lH, 5, CH(OEt)2]' 4.84 (lH, br m, 9-H), 5.09
(lH, s , 5-H), 6.22 (2H, s , 7-H and 8-H), 6.61 (lH, d, J2-H 8 Hz, 1-H),
and 6.74 C1H, d, Jl-H 8 Hz, 2-H); 0C(CDC13) 15.07 (q), 27.98 (t?),
28.39 (q), 30.10 (t?), 38.20 Cd?), 46.60 (s), 53.61 (d), 54.81 (5),
56.88 (q), 62.76 et), 80.98 (s), 88.13 (d), 98.37 (d), 115.54 (d),
119.43 (d), 123.95 (s), 128.75 (s), 135.33 (d), 138.70 (d), 143.10 (5),
145.07 (5), 155.98 (s), 167.83 (s}, and 193.22 (5).
14S -('l',~-Diethoxyethanoyl.amino rN-t-butoxycarbonylnorcodeine (70). -
\
To a stirring suspension of the norcodeinone (69) (62 mg, 0.12 mmo1) in
anhydrous ethanol (2 ml) was added sodium borohydride (5 mg, 0.13 mmo1).
Stirring was continued for 30 min at room temperature, the solvent was
evaporated and water was added. The aqueous mixture was extracted with
chloroform (4 x 3 ml) and the extracts were dried and evaporated. The
residue was chromatographed on a silica plate [methanol-chloroform (1:9)]
to afford the norcodeine (70) (Rf 0.61) (46 mg, 74%) as an oil (Found:
+M 530.2627. C2sH3sN20s requires M, 530.2628); v (CHC13) 3 690, 3 565,max
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3 420,3 390, and 1 690 cm-I; 6(COC13) 1.21 [6H, br t , JCHz 7 Hz,
tCH(OCHzCH3hJ, 1.44 (3H, s, Bu ), 3.60 [4H, br q, JCH3 7 Hz,
CH(OCHzCH3)z], 3.85 (3H, s , OMe·), 4.70 [lH, s , CH(OEth]t 4.95 (2H,
br s, 5-H and 6-H), 5.82 (lH, br m, 7-H and 8-H), 6.56 (lH, d, Jz-H
8 Hz, I-H), 6.70 (lH, d, JI-H 8 Hz, 2-H), and 7.00 (lH, br s, NH).
14e-(2,2-Dimethoxyethanoylamino Inoroodeinone (71). - The norcodei none
(69) (53 mg, 0.1 mmol) in methanol (3 ml) containing concentrated
hydrochloric acid (1 ml) and 5M hydrochloric acid (1 ml) was heated
at 60°C for 30 min. The solution was basified with sodium hydroxide
so1ution, extracted with chloroform (4 x 5 ml), and the extracts were
dried and evaporated to yield the crude noraodeinone (71) (8 mg, 20%)
which crystallised from ethyl acetate as fine needles, m.p. l69-l72°C
(Found: M+, 400.1669. CZIHz4N206 requires 400.1634); vrnax(CHC13) 3 370
and 1 695 cm-I; o(COC13) 3.40 (3H, 5, CHOCH3), 3.46 (3H, 5, CHOMe),
3.84 (3H, 5, 3-0Me), 4.62 [lH, 5, CH(OMe)2]' 4.92 (lH, 5, 5-H),6.l8
(2H, 5, 7-H and 8-H), 6.55 (lH, d, J2-H 8 Hz, l-H), 6.70 (lH, d, JI-H
8 Hz, 2-H), and 7.65 (lH, br 5, exchangeable with 020, NH).
6s, 14e-(N-Pheny~aetylepoxyimino)-6, 14-dihydrothebaine (73; R = Ph). -
Thebaine (3.11 g, 10 mme1) in ethyl acetate (150 m1) and sodium periodate
(3.21 g, 15 mmo1) in aqueous sodium acetate (0.2M, adjusted to pH 5.8
with concentrated hydrochloric acid) (100 ml) were stirred rapidly at
DoC .. Phenylacetohydroxamic acid41 (2.27 g, 15 mmol) was added slowly
'.
over 15 min, then rapid stirring was continued for 1 h. The mixture was
basified with aqueous sodium hydrogen carbonate and the layers separated ..
The aqueous layer was extracted with ethyl acetate (2 x 100 ml) and the
combined ethyl acetate layers were washed with 5% sodium thiosulphate
solution (2 x 100 ml), dried, and evaporated to give the cyc loadduct (73;
R = Ph) which crystallised from methanol-diisopropyl ether (3.83 g, 83%),
m.p. 148-149°C (lit.,14 l46-l46.s0C); v (KBr) 1 680 cm-I; 6(COC13) 2.40max
(3H, 5, NMe), 3.47 (3H, 5, 6-0Me), 3.55,3.81 (2H, d, d, J 16 Hz, CH2Ph),
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3.80 (3H, s, 3-0Me), 4.61 (lH, s, s-H), 4.84 (lH, d, J10CL-H 7 Hz, 9-H),
5.93 (lH, d , JS-H 9 Hz, 7-H), 6.11 (lH, d, J7_H 9 Hz, 8-H), 6.53 (lH, d,
J2-H 7 Hz, I-H), 6.67 (lH, d, JI-H 7 Hz, 2-H), and 7.05-7.45 (5H, m, Ph).
14S~2-Ethoxy-2-phenyLethanoyZamino)codeinone (74). - The cycloadduct
(73; R = Ph) (93 mg, 0.2 mmel) was dissolved in anhydrous ethanol (2 ml)
and sodium ethoxide solution added (0.64 m1, 1 mol equiv.) [from
sodium (72 mg, 3.13 mmol) in anhydrous ethanol (10 ml)]. The solution
was stirred at room temperature for 30 min, diluted with water, and
evaporated to near dryness (at 20°C). Chloroform (5 ml) was added and
the solution washed with brine (2x5 ml) and water (2 ml), dried, and
evaporated to yield the codeinone (74) which crystallised from ethanol
as granules (36 mg, 38%), m.p. 198-199°C (Found: C, 70.90; H, 6.55;
N, 5.97; M+, 474.2158. CZSH30NzOs requires e, 70.87; H, 6.37; N, 5.90%;
M, 474.2155); v (CHC13) 3 370,3 210, and 1 690 cm-I; o(COC13) 1.24max
(3H, t, JCH2 7 Hz, CH3), 2.47 (3H, s, NMe), 3.54 (2H, q, JCH3 7 Hz, CHz),
3.80 (3H, s, OMe), 4.66 (lH, s, 5-H or CHPh), 4.68 (lH, s, 5-H or CHPh),
6.20 (2H, s, 7-H and 8-H), 6.54 (lH, d, JZ-H 7 Hz, I-H), 6.66 (lH, d,
JI-H 7 Hz, 2-H), 7.25-7.55 (5H, m, Ph), and 7.88 (lH, br s, exchangeable
with OzO, NH).
l4S-[(S)-2-Methoxy-2-phenyZethanoylamino]codeinone (75a). - The
cycloadduct (73; R = Ph) (93 mg, 0.2 mmo1) was dissolved in anhydrous
methanol (2 ml) and sodium methoxide solution added (0.75 ml, 1 mol
'.
equiv.) [from sodium (61 mg, 2.65 1111101)in anhydrous methanol (10 ml)J.
The solution was stirred at room temperature for 16 h, diluted with
water, and evaporated to dryness (at 20°C). Chloroform (5 ml) was
added and the solution washed with brine (2 x 5 ml) and water (5 ml), dried,
and evaporated. The residue was filtered through a short column of
silica to give the codeinone (7Sa) which crystallised from ethanol as
cuboids (34 mg, 37%), m.p. l78-179°C (Found: C, 70.58; H, 6.12; N, 6.24;
M+,460.2028. CZ7HzsNzOs requires C, 70.42; H, 6.13; N, 6.08%; M, 460.1998);
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vmax(CHC13) 3 370 and 1 690 cm-I; o(COC13) 2.46 (3H, 5, NMe), 3.37
(3H, 5, CHOMe), 3.80 (3H, 5, 3-0Me), 4.54 (1H, s, CHPh), 4.69 (1H, s,
5-H), 6.20 (2H, 5, 7-H and 8-H), 6.55 (lH, d, J2-H 8 Hz, 1-H), 6.68
(lH, d, J1-H 8 Hz, 2-H), 7.41 (5H, br 5, Ph), and 7.79 (lH, br 5,
exchangeable with 020, NH); 0C(COC13) 21.20 (t), 28.17 (t), 42.74 (q),
46.02 (t), 46.13 (5), 54.03 (5),56.93 (q), 57.26 (q), 62.97 (d),
84.51 (d)~ 87.90 (d), 115.25 (d), 118.96 Cd), 125.01 (s), 126.85 (d),
128.62 (d), 129.64 (s), 135.62 (d), 137.10 (5),139.96 (d), 142.77 (5),
144.68 (5), 170.51 (s),and 193.84 (5).
(S) -(+)~-MetJvxyphenyl,aaetw Aaid. - The procedure of Reeve and
Christoffe161 was followed using (+)-mande1ic acid (7.61 g) and
dimethyl sulphate (26 m1, 5.5 mol equiv.). (S)-{+)-a-Methoxyphenylacetic
acid crystallised from ethyl acetate-light petroleum (2.57 g, 31%),
m.p , 65-66°C (lit.,76 65-66°C); [a]t5+144.2°(Cl EtOH) (lit.,76 +150°).
(R}-(-}-a~ethoxyphenyl,aaetia Aaid. - The procedure of Reeve and
Christoffe161 was followed using {-)-mande1ic acid (7.61 g) and
dimethyl sulphate (26 ml, 5.5 mol equiv.). {R)-(-)-a-Methoxypheny1acetic
acid crystallised from ethyl acetate-light petroleum (2.61 g, 31%),
25m.p. 65-66°C {lit.,76 65-66°C}; [a]O -148.3° (cl, EtOH) (lit.,76 -150.7°).
14a-[(S)~ethoxy-2-phenyLethanoyZamino]aodeinone (75b) from
14a-Aminoaodeinone. - 14s-Aminocodeinone C234 mg, 0.75 mmol) and
(s)-a-methoxypheny1acetic acid (137 mg, 0.83 mmol) were dissolv~d in
\
methylene chloride (15 ml). This solution was added to a solution of
NN-dicyc1ohexy1carbodiimide (185 mg, 0.9 mmol) in methylene chloride
(15 m1) and the reaction mixture was stirred at room temperature for
30 min. Glacial acetic acid (15 drops) was added, the precipitate
filtered off and the filtrate concentrated. The residue was treated
with acetone, whereupon more of the by-product precipitated and was
filtered off. Evaporation of the filtrate afforded the codeinone (75b)
which crystallised from ethyl acetate-light petroleum as cuboids (234 mg,
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68%), m.p. 178-179°C, mixed m.p. (with 75a) 177-1.78°C, [a]~S+65° (cO.5,
+EtOH) (Found: C, 70.56; H, 5.97; N, 6.35; M , 460.1981. Calc. for
C27H2sNzOs: C, 70.42; H, 6.13; N, 6.08%; M, 460.1998); vmax(CHC13)
3 370 and 1690 cm-I; o(CDC13) 2.46 (3H, 5, NMe), 3.38 (3H, 5, CHOMe),
3.80 (3H, s, 3-0Me), 4.55 (lH, s, CHPh), 4.68 (lH, 5, 5-H), 6.19 (2H,
s, 7-H and 8-H), 6.54 (lH, d, J2_H 8 Hz, l-H), 6.68 (lH, d, J1-H 8 Hz,
2-H), 7.25-7.55 (5H, m, Ph), and 7.75 (lH, br 5, NH).
14S-[(RJ-Methoxy-2-phenytethanoytamino]aodeinone (78) from
14S-Aminoaodeinone. - 14s-Aminocodeinone (234 mg, 0.75 mmol) and
(R)-a-methoxyphenylacetic acid (137 mg, 0.83 mmol) were dissolved in
methylene chloride (15 m1). This solution was added to a solution of
NN-dicyclohexylcarbodiimide (185 mg, 0.9 mmo1) in methylene chloride
(15 m1) and the reaction mixture was stirred at room temperature for
30 min. Work-up as before afforded the aodeinone (78) which crystal-
lised from ethanol as prisms (291 mg, 84%), m.p. 202-203°C, [C1]~5 +94.6°
+(c 0.5, EtOH) (Found: C, 70.50; H, 6.23; N, 5.91; M , 460.2021.
C27H2sN20s requires e, 70.42; H, 6.13; N, 6.08%; M, 460.1998); v (CHC13)max
3 260 and 1 690 cm-I; o(CDC13) 2.44 (3H, s, NMe), 3.43 (3H, s, CHOMe).
3.82 (3H, s, 3-0Me), 4.58 (lH, s , CHPh), 4.93 (lH, s , 5-H), 6.06 (2H. 5"
7-H and 8-H), 6.56 (lH, d, J2-H 8 Hz, 1-H), 6.69 (lH, d, J1-H 8 Hz, 2-H),
7.32 (SH, 5, Ph), and 7.87 (lH, br 5, NH).
l4S-(N-2-PhenytethanoythydroxyaminoJaodeinone (79). - The cyclo-
adduct (73; R = Ph) (1.15 g, 2.5 mmol) in methanol (50 m1) containing
6M hydrochloric acid (50 m1) was heated at 65°C for 30 min. The
solution was basified with sodium hydrogen carbonate and extracted with
chloroform (4 x 50 ml). The combined extracts were washed with water
(50 ml), dried, and evaporated. The aodeinone (79) crystallised from
chloroform-methanol as the hemi-hydrate (0.453 g, 40%), m.p. 167-169°C
(Found ; C, 68.82; H, 5.91; N, 6.29; [Mt {-~H20} , 446.1847. e26H26N20S.~H20
requires e, 68.55; H, 5.97; N, 6.15%; [M] {-~H20}, 446.1842); vmax(CHC13)
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3 640,3 580, 3 365, 3 250, 1 690, and 1 645 cm-I; 8(COC13) 2.45
(3H, s, NMe), 3.70 (lH, br d, J10a-H 5 Hz, 9-H), 3.82 (5H, s, OMe and
CH2Ph), 5.03 (lH, s, 5-H), 6.12 (lH, br s, exchangeable with 020, OH),
6.14 (2H, s, 7-H and 8-H), 6.56 (lH, d, J2-H 8 Hz, l-H), 6.68 (lH, d,
JI-H 8 Hz, 2-H), and 7.28 (sH, s, Ph).
58,148-(N-Phenylacetylepoxyimino)thebainone (81). - To a stirred
suspension of the codeinone (79) (61 mg, 0.13 mmol) in anhydrous
ethanol (2 ml) was added sodium ethoxide solution (1.52 ml, 4.2 mol
equiv.) [from sodium (83 mg, 3.6 mmol) in anhydrous ethanol (10 ml)].
Stirring was continued for 5 min at room temperature and then the
ethanol was evaporated. The residue was dissolved in chloroform (10 ml)
and the solution was washed with brine (2 xlO ml) and water (10 ml),
dried, and evaporated. The crude product was chromatographed on a
silica plate [methanol-chloroform (1 :9)] to yield the phenoZ (81)
(Rf 0.45) (29 mg, 49~) as an oil (Found: M+, 446.1842. C26H26N20S
requires M, 446.1842); vmax(CHC13) 3 540, 3 400, and 1 690 cm-I;
8(COC13) 2.44 (3H, s, NMe), 3.80 (3H, s, OMe), 4.27 (lH, br d, JIOa-H
7 Hz, 9-H), 5.17 (lH, br s, s-H), 5.78 (lH, dd, Ja-H 10 Hz, and JS_H
2 Hz, 7-H), 5.80 (lH, br s, exchangeable with 020, OH), 6.63 (2H, s,
l-H and 2-H), 7.00 (lH, d, J7-H 10 Hz, 8-H), and 7.25-7.45 (sH, m, Ph).
The Anhydro-base, 'buttercup' (82). - The codeinone (79) (90 mg,
0.2 mmol) in anhydrous pyridine (4 ml) was treated with toluene-p-sulphonyl
chloride (40 mg, 0.2 mmol) for 6 h at room temperature. The solution
was evaporated and the residual pyridine removed by azeotroping with
toluene (4x). The residue was dissolved in methanol (4 ml), sodium
methoxide solution (1.57 ml, 4 mol equiv.) [from sodium (117 mg, 5.09 mmol)
in methanol (10 ml)] was added and the solution stirred at room
temperature overnight. The resultant precipitate was filtered off to
give 'buttercup' (82) (30 mg, 30%) which was.recrystallised from
chloroform-methanol as golden yellow needles, m.p. 285°C (decomp.)
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(Found: C, 69.80; H, 5.53; N, 7.93; [M]+ {-H20-!MeOH}, 505.2003. C31H27N30Lp
H20.~MeOH requires C, 70.11; H, 5.76; N, 7.79%; [M] {-H20 - ~MeOH},
505.2001); Amax(EtOH) 339.5 (€ 11 920) and 435 nm (€ 7 150); Amax(EtOH +
TFA) 352 nm (e 7 920); vrnax(KBr) 1 720, 1 635, and 1485 cm-l;
vrnax(CHC13) 3 415, 1 720, 1 635, and 1 485 cm-l; o(CDC13, 250 MHz)
2.19 (3H, s, NMe), 3.49 (1.5H, s, MeOH of crystallisation), 3.83 (lH, s,
8-H), 3.90 (3H, s, OMe), 4.59 (lH, s, 5-H), 6.40 (lH, dt, J61_H 1.5 Hz,
JS'_H 7 Hz, J31-H 7 Hz, 41_H), 6.55 (lH, d, J2-H 8 Hz, H-l), 6.72 (lH,
d, J1-H 8 Hz, 2-H), 7.01 (lH, br td, J61-H 1.5 Hz, Jsl-H 1.5 Hz, J41-H
7 Hz, 31-H), 7.42 (lH, ddd, J61-H 9 Hz, J41-H 7 Hz, J31-H 1.5 Hz, 51-H),
7.51 (5H, br s, Ph), 7.56 (lH, br s, exchangeable with O2°, NH), and
7.97 (lH, br td, Jsl-H 9 Hz, J41-H 1.5 Hz, J31-H 1.5 Hz, 61-H);
0C(COC13) 22.05 (t), 31.96 (t), 43.22 (q), 45.85 (t}, 46.08 (5), 51.78
(d), 57.20 (q), 61.55 (s), 63.95 (d), 81.49 (s), 90.32 (d), 94.39 (s),
112.81 (d), 115.76 (d), 118.53 (d), 118.62 (d), 125.33 (s), 128.72 (d),
129.73 (d), 130.30 (d), 134.56 (d), 134.79 (s), 140.59 (d), 143.10 (5),
145.78 (5), 153.12 (5), 169.90 (s), and 178.32 (s).
2-pyridylacetone. - The method of Burger and U11yot77 was
followed using ~-pico1ine (25 g, 0.27 mol), lithium (3.25 g, 0.46 mol),
bromobenzene (36.75 g, 0.23 mol), and acetonitrile (12.4 m1, 0.23 mol).
2-Pyridylacetone (8.45 g, 23%) was isolated as an oil, b.p. 110-115°C
'\ (ca. 5 om Hg).
2~cetonyLidene-l-benzyL-l,2~ihydropyridine65 (83c). - 2-Pyridyl-
acetone (1.01 g, 7.5 mmo1) and benzyl bromide (0.89 m1, 7.5 mmol) were
heated together on a steam bath for 4 h. The viscous residue was
trf turated with acetone (6 x) to yield a syrupy quaternary bromide which
was shaken with water and chloroform. The aqueous layer was cooled and
basified with 5% aqueous sodium hydroxide. The resultant golden-yellow
precipitate was filtered off to give the dihydropyridine (83c) (0.304 g,
18%), m.p. 125-127°C (decomp.) (lit.,65 124-125°C); Amax(EtOH)
109
326 (8 la 320) and 396 nm (8 8 580); Amax(EtOH + TFA) 346 nm (£ 1 680);
vmax(KBr) 1 640 and 1 505 em-I; o(CDC13) 1.96 (3H, s, CH3), 4.91 (2H,
s , CH2), 4.96 (lH, s, CHCO), 6.18 (lH, dt, J6-H ca. 1.5 Hz, Js-H 6 Hz,
J3-H 6 Hz, 4-H), 7.00-7.55 (7H, m, 3-H, 5-H and Ph), and 8.93 (lH, dd,
JS_H 10 Hz, J4-H ca. 1.5 Hz, 6-H); 0C(CDC13) 31.19 (q), 57.52 (t),
88. 57 (d), 109.45 (d), 122.97 (d), 126.77 (d), 128. 15 (d), 129. 11 (d),
134.04 (s), 134.79 (d), 138.02 (d), 152.67 (s), and 191. 35 (s).
2-Acetony~idene-1~ethy~-1~2~ihydropyridine (83d). - 2-Pyridy1-
acetone (1.01 g, 7.5 mmo1) and methyl iodide (0.47 m1, 7.5 rnmo1) were
heated together on a steam bath for 1 h. The viscous residue was
triturated with acetone (6 x) to yield the quaternary ammonium iodide
(1.193 g, 58%), m.p. 141-144°C.
The quaternary ammonium iodide (500 mg, 1.8 mmo1) was dissolved
in water, cooled to O°C and basified with 5% aqueous sodium hydroxide.
The aqueous sol ution was extracted wi th ch 1oroform (6 x la m1) and the
extracts were dried and evaporated to yield the dihydropyridine (83d)
[223 mg, 40% (from 2-pyridylacetone)] which crystallised from ethyl
acetate as golden yellow needles, m.p. 109-ll0°C (decamp.) (Found:
C, 72.23; H, 7.59; N, 9.31; M+, 149.0845. C9HIlNO requires C, 72.48;
H, 7.38; N, 9.39%; M, 149.0841); Amax(EtOH) 322 (8 5 290) and 390 nm
(£ 4 550); Amax (EtOH + TFA) 340 nm (€ 600); vmax(KBr} 1 640 and
1 505 cm-l; o(CDC13) 2.10 (3H, s, COCH3), 3.40 (3H, ~~ NCH3), 4.93
(lH, s, CHCO), 6.13 (lH, dt, J6-H 1.5 Hz, Js-H 6.7 Hz, J3-H 6.7 Hz,
4-H), 6.96-7.25 (2H, m, 3-H and 5-H), and 8.88 (lH, td, Js-H 10 Hz,
J4-H 1.5 Hz, J3-H 1.5 Hz, 6-H); 0C(CDC13) 31.20 (q), 42.64 (q), 87.39
(d), 109.19 (d), 121.94 (d), 134.89 (d), 138.42 (d), 153.02 (s), and
190.95 (s).
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l-Methoxy-4-methyL-l~3-cyalohexadiene (86). - (a) Birah reduction
of p-methylanisole. The procedure of Monti et al.67 was followed using
p-methylanisole (24.4 g, 0.2 mol), lithium (5.6 g, 0.8 mol), dry
t-butanol (100 m1), and dry THF (100 ml) in dry liquid ammonia (500 m1).
A 1:1 mixture of the 1,3- and 1.4-dienes was isolated which was
distilled (18.86 g, 76%), b.p. 56-58°C (aa. 15 mm Hg).
(b) Isomerisation of the diene mixture. The procedure of Birch
and Dastur29 was followed and afforded, from the diene mixture (9 g)
and toluene-p-sulphonic acid (9 mg), a liquid (7.76 g, 86%), b.p.
58-60°C (aa. 15 mm Hg). N.m.r. spectroscopy showed this to contain
the 1,3-isomer (72%) and the 1,4-isomer (28%).
4-MethyL-4-(N-2-phenylethanoylhydroxyaminoJ-2-cyalohexenone (88). -
The diene mixture (86) (3.44 g, 20 mmo1 of 1,4-diene) in ethyl acetate
(300 m1) and sodium periodate (6.42 g, 30 mmol) in aqueous sodium
acetate (0.2M, adjusted to pH 5.8 with concentrated hydrochloric acid)
(200 m1) were stirred rapidly at DoC. Pheny1acetohydroxamic acid
(4.53 g, 30 mmo1) was slowly added over 15 min, then rapid stirring
was continued for 1 h. The mixture was basified with aqueous sodium
hydrogen carbonate and the layers separated. The aqueous layer was
extracted with ethyl acetate (2 x 100 m1) and the combined ethyl acetate
layers were washed with 5% sodium thiosulphate solution (2 x 100 ml) and
,
'\ water (100 m1), dried, and evaporated. The residue was chromatographed
under reduced pressure on a silica column (100 g). The fractions eluted
with ethyl acetate-light petroleum (1:1) and which gave a purple colour
with ferric chloride solution were combined. Crystallisation from
ethyl acetate afforded the ayalohexenone (88) [1.10 g, 21% (based on
1,4-diene)] as cuboids, m.p. 136-137°C (Found: e, 69.32; H, 6.74;
N, 5.34; M+, 259.1208. elsH17N03 requires e, 69.48; H, 6.61; N, 5.40;
M, 259.1208); vmax(KBr) 3 140 and 1 675 cm-I; 6(eDC13) 1.50 (3H, s, CH3),
1.85-2.85 (4H, m, CH2CH2CO), 3.81 (2H, s, CH2Ph), 5.82 (lH, d, J3-H 10 Hz,
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2-H), 6.94 (lH, br s, exchangeable with OzO, OH), 7.07 (lH, d, JZ_H
10 Hz, 3-H), and 7.27 (SH, s, Ph).
The Anhydro-base, 'neo-buttercup' (84). - The cyclohexenone (88)
(259 mg, 1 mmol) in anhydrous pyridine (5 ml) was treated with toluene-
p-sulphonyl chloride (210 mg,l.l mmo1) for 38 h at room temperature.
The solution was evaporated and the residual pyridine removed by
azeotroping with toluene (4 x). The residue was dissolved in methanol
(5 ml) and sodium methoxide solution (4.6 ml, 4 mol equiv.) [from
sodium (199 mg, 8.65 mmol) in methanol (10 ml)] was added and the
solution was stirred at room temperature for 5 h. The methanol was
evaporated and the residue treated with water and extracted with
chloroform (4 x 25 ml). The combined extracts were dried and evaporated
to yield 'neo-buttercup' (84) which crystallised from methanol-
ethyl acetate as cuboids (72 mg). A second crop (8 mg) was obtained
by chromatographing the mother liquors on silica plates [methanol-
chloroform (1 :9)] (Rf 0.32). Total yield 80 mg, 25%, m.p. 300-301·e
(decamp.) (Found: e, 75.18; H, 5.76; N, 8.65; M+, 318.1361.
CZOH18NzOz requires C, 75.45; H, 5.70; N, 8.80; M, 318.1368);
Amax(EtOH) 336 (€ 4 880) and 435 nm (€ 2 120); Amax(EtOH + TFA) 360 nm
(€ 2 440); 'Jmax(KBr) 1 705,1635, and 1 500 cm-I; 'Jmax(CHC13) 3 415,
1 710,1 640, and 1 500 em-I; o{COC13, 250 MHz) 1.24 (3H, s, CH3),
1.69-2.28 {4H, m, eHzeH2}, 3.72 (lH, s, 3-H), 6'.J4 (lH, dt, J61 -H 1.5 Hz,
\
Jsl-H 7 Hz, J31 -H 7 Hz, 41-H), 6.52 (lH, br s, NH), 7.05 (lH, td,
J61 -H 1.5 Hz, JSI_H 1.5 Hz, J41 -H 7 Hz, 31-H), 7.23 (lH, ddd, J61 -H 9 Hz,
J41-H 7 Hz, J31-H 1.5 Hz, 51-H), 7.41-7.50 (5H, rn, Ph), and 7.65 (1H,
td , J 51 -H 9 Hz, J 41 -H 1.5 Hz, J 31 -H 1.5 Hz, 6 I -H); 0C (CD3 OD) 28.16 ,
37.37,40.26, 59.26 (s), 60.45 (d), 83.07 (s), 96.07 (s), 113.26 (d),
118.15 (d), 128.90 (d), 130.64 (d), 137.06 (d), 139.35 (s), 141.75 (d),
153.19 (s), 171.88 (s), and 190.20 (s).
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AZternative Preparation of 'neo-buttercup' (84). - A solution
of the hydroxamic acid (88) (52 mg, 0.2 mmol) in dry methylene
chloride (1 ml) containing triethylamine [0.61 ml (10% solution in
methylene chloride), 0.44 mmo1] was cooled to -70°C and trif1uoro-
methanesulphonic anhydride (37 ul, 0.22 mmol) added. After stirring
for 10 min at -70oe dry pyridine (80 ul, 1 mmo1) was added and the
solution warmed to room temperature (aa. 20 min). The solution was
evaporated and the residue dissolved in methanol (1 m1) and treated
with sodium methoxide solution (2 ml, 4 mol equiv.) [from sodium
(90 mg, 3.9 mmol) in methanol (10 m1)]. After stirring at room temper-
ature overnight the solvent was evaporated and water was added. The
solution was extracted with chloroform (4x5 ml) and the extracts were
dried and evaporated. The residue was chromatographed on a silica
plate [methanol-chloroform (1:9)] (Rf 0.24) to afford 'neo-buttercup'
(84) which crystallised from methanal (16 mg, 25%). The n.m.r. spectrum
was identical to that obtained in the above route.
14S-(2-ChZoro-2-pnenyZethanoyZamino)aodeinone (89). - A solution
of (±)-a-ch1oropheny1acetyl ch1oride78 (227 mg, 1.2 mmo1) in ethyl
acetate (10 m1) was added dropwise to a stirred solution of 14a-amino-
codeinone (312 mg, 1 mmol) in ethyl acetate (10 m1) containing powdered
anhydrous potassium chloride (552 mg, 4 mmo1). Stirring was continued
for 30 min, water was added and the two layers separated. The aqueous
1ayer was extracted wi th ethyl acetate (2 x 20 m1) and the combi ned
ethyl acetate layers were washed with water (20 m1), dried, and evaporated.
Tne residue was chromatographed on silica plates [methanol-chloroform ~ :9))
(Rf 0.66) to afford the codeinone (89) as a mixture of diastereoisomers
which crystallised from methylene chloride-methanol as fine needles
(257 mg, 55%), m.p. 218-220°C (decomp.) (Found: e, 67.27; H, 5.45;
N, 6.03; M+ 466.1519,464.1513. e26H2sC1N204 requires C, 67.16; H, 5.42;
N, 6.03%; M, 466.1473,464.1503); vmax(KBr) 1 685 cm-I; o(CDC13) 2.42
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(6H, s, NMes), 3.82 and 3.83 (each 3H, s, OMes), 4.75 and 4.88 (each
lH, s, 5-Hs), 5.29 and 5.35 (each lH, s, CHPhs), 6.17 and 6.19 (each
2H, s, 7-Hs and 8-Hs), 6.58 (2H, d, J2-H 8 Hz, 1-Hs), 6.70 (2H, d,
JI-H 8 Hz, 2-Hs), 7.25-7.60 (10H, m, Phs), and 7.82 and 8.11 (each
1H, br 5, NHs).
A tterrrptedPreparation of the Pyridiniwn Chl-oride (85). - The
codeinone (89) (23 mg, 0.05 mmol) was stirred in dry pyridine (0.5 ml)
overnight at room temperature. Evaporation of the solvent yielded
starting material, identified by its n.m.r. spectrum. Starting
material was also isolated when the codeinone was refluxed in, (i) 10%
pyridine-benzene, and (ii) 10% pyridine-toluene. In ref1uxing pyridine
the codeinone decomposed.
N-t-autyZhydroxyZamine (90). - N-t-Butylhydroxylamine was prepared
fol1owing the procedure of Calder, Forrester and Hepburn?9 Thus,
oxidation of N-t-butylamine with potassium permanganate to give 2-methyl-
2-nitropropane which was reduced with aluminium amalgam to N-t-butyl-
hydroxylamine in an.overall yield of 24% (m.p. 63-64°C) (lit.,79 64-65°C).
a-ChZoro-N-t-butyZphenyZaaetamide (94) tram N-t-Butyl-amine. - A
solution of a-chlorophenylacetyl chloride7s (4.52 g, 24 mmo1) in anhydrous
ether (20 ml) was added dropwise to a stirred solution of N-t-buty1amine
(5.07 ml, 48 mmol) in anhydrous ether (20 m1) at O°C. Stirring was
continued for 1 h, ether (60 ml) added and the mixture was washed with
5% hydrochloric acid (2 x 50 m1) and water (50 m1), dried, and evaporated
to yield the amide (94) whith crystallised from ethyl acetate-light
petroleum (3.9 g, 73%), m.p. 131-132°C (lit.,eo 120-130°C) (Found:
+M , 227.0893, 255.0912. Calc. for C12H1SC1NO: M, 227.0891, 225.0920);
vmax(CHC13) 3 420 and 1 680 cm-I; o(CDC13) 1.36 (9H, s, But), 5.26 (lH,
s, CH), 6.55 (lH, br s, exchangeable with °20, NH), and 7.25-7.50 (SH,
m, Ph).
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a.-GhZoro--1'i-t-buty Zpheny lace tamide (94)from N-t-Bu ty Zhydroxy Lanrine . -
To a stirred solution of N-t-butylhydroxylamine (134 mg, 1.5 mmo1) in
dry ether (3 ml) containing powdered anhydrous potassium carbonate (414 mg,
3 mmel) was added acetic anhydride (0.14 m1, 1.5 mmo1). After stirring
for 4 h at room temperature the inorganic solids were filtered off,
washed with ether and the filtrate was evaporated to afford o-acety1-N-
t-butylhydroxylamine (91) as an oil. This material was dissolved in
dry benzene (3 ml) and dry pyridine (0.13 ml, T.6 mmoT) and phenyTacety1
chloride (0.21 mT, l.6 mmol) added. The mixture was heated under reflux
for 3 h, cooled, diluted with benzene (7 m1), and washed with 5%
hydrochloric acid (2x5 m1), 5% sodium hydroxide solution (2x5 ml), and
water (5 ml). The dried benzene solution was evaporated to give an oily
solid. The amide (94) was sublimed from this residue (bath temp.
110-120°C, ca. 15 mm Hg) and recrystallised from ethyl acetate-light
petroleum (103 mg, 30%), mixed m.p. (with authentic amide) 131-132°C;
to(CDC13) 1.36 (9H, 5, Bu), 5.25 (lH, s, CH), 6.52 (lH, br s, NH), and
7.25-7.50 (5H, m, Ph).
N-t-futylphBnyZacetohydroxarrric Acid68 (93). - To a stirred solution
of N-t-butylhydroxylamine (890 mg, la mmo1) in methylene chloride (10 ml)
was added triethylamine (1.6 m1, 11 mmo1) and trimethy1chTorosiTane
(1.4 ml, 11 mmel). The mixture was stirred for 10 min, cooled to ooe
and treated with triethylamine (1.6 m1, 11 mmo1) followed, dropwise, by
ph enyl acetyl chToride (1.45 m1, 11 mmo 1) . After the mi xture had warmed
to room temperature (ca. 30 min) methylene chloride (la m1) and 5%
hydrochloric acid (10 ml) were added and the two layers separated. The
organic layer was washed with 5% hydrochloric acid (10 m1) and water (10 ml),
dried, and evaporated to give an oily solid. The crystals were filtered
off and recrysta11ised from ethyl acetate-light petroleum to give the
hydroxamic acid (93) as prisms (621 mg, 32%), m.p. 129-130oe (Found:
et 69.30; H, 8.25; N, 6.68; M+, 207.1261. C12H17N02 requires e, 69.53;
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H, 8.27; N, 6.76%; M, 207.1259); vmax(CC14) 3 200, 1 670, and 1 615 cm-I;
t8(CDC13) 1.37 (9H, s, Bu ), 3.71 (2H, s, CH2), 7.05 (lH, br 5, exchange-
able with D20, OH), and 7.20 (5H, br s, Ph).
NO-8i5phenyZaaetyZ~-t-butyZhydroxyZamine (95). - To a sol ution of
the hydroxamic acid (93) (42 mg, 0.2 mmo1) in dry benzene (2 m1) was
added dry pyridine [0.18 ml, (10% solution in dry benzene), 0.22 mmol]
and phenylacetyl chloride (0.03 ml, 0.22 mmol). The solution was
stirred at room temperature overnight, diluted with benzene (5 ml), and
washed with 5% hydrochloric acid (2 x 3 ml), 5% sodium hydroxide solution
(2x3 ml) and water(3 m1). The organic solution was dried and evaporated
and the crude product was chromatographed on a silica plate [ethyl
acetate-light petroleum (1:4)] to yield the hydroxylamine derivative (95)
(Rf 0.45) (47 mg, 71%) as an oil (Found: M+ 32'5.1673. CZOHZ3N03
requires M, 325.1678); vrnax(CHC13) 1 780 and 1 670 cm-I; o(CDC13) 1.35
t(9H, 5, Bu ), 3.37 (2H, s, OCOCH2Ph), 3.71 (2H, s, NCOCH2Ph), and
7.00-7.50 (lOH, m, Phs).
Attempted Preparation of a-ChZoro,~-t-butyZphenylaaetamide (94)
from NO-OiphenylaaetyZ-N-~butythydroxyZamine (95). - To a solution
of the hydroxylamine derivative (95) (52 mg, 0.16 mmo1) in methylene
chloride (2 m1) was added tetrabuty1ammonium chloride (115 mg, 0.41 mmol)
and triethylamine (0.05 m1, 0.36 mmo1). The solution was refluxed for
3 h, coaTed, diluted with methylene chloride (5 ml), and washed with
5% hydrochloric acid solution (2 x 2 ml), 5% sodium hydroxide solution
(2 x 2 ml Land water (2 ml). The organi c solution was dried and
evaporated to yield starting material, identified by n.m.r , spectroscopy.
Starting material was also recovered when the procedure was repeated
uSing, (i) tetrabutylammonium chloride and triethylamine in methylene
chloride at room temperature, (ii) tetrabutylammonium chloride and
pyridine in benzene at room temperature, (iii) tetrabutylammonium
chloride and pyridine in refluxing benzene, and (iv) pyridine
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hydrochloride and pyridine in refluxing methylene chloride.
a.-ChJ.,oro-N-t~utyJ.,phenyZacetamide (94) from N-t-Butylphenylaaeto-
hydroxamic acid (93). - The hydroxamic acid (93) (126 mg, 0.61 mmol)
in methylene chloride (4 ml) was treated with triethylamine (93 ~l,
0.67 mmol) and toluene-p-sulphonyl chloride (117 mg, 0.61 mmol) for
2 days at room temperature. The solution was diluted with methylene
chloride (5 ml) and washed with 5% hydrochloric acid (2 x 3 ml), 5%
sodium hydroxide solution (2 x 3 m1), and water (3 ml). The organic
solution was dried and evaporated to give an oily solid. The amide
(94) was sublimed from this residue (bath temp. 110-120°C, ca. 15 mm Hg)
and recrystallised from ethyl acetate-light petroleum (40 mg, 29%),
mixed m.p. (with authentic amide) l30-l31oC'; o(CDC13) 1.37 (9H, 5, But),
5.25 (lH, s, CH), 6.53 (lH, br s, NH), and 7.25-7.50 (SH, m, Ph).
I-t-ButyZ-3-PhenyZaziridin-2-one49 (63). - A solution of the
hydroxamic acid (93) (52 mg, 0.25 mmo1) in dry methylene chloride (2 ml)
containing triethylamine (77 ~l, 0.55 mmol) was cooled to -70°C. Tri-
fluoromethanesulphonic anhydride (47 ~l, 0.29 mmol) was added, the
solution was warmed to room temperature (aa. 30 min) and then diluted
with methylene chloride (5 ml). The solution was washed with water (2 ml),
dried, and evaporated. The residue was extracted with light petroleum
(40-60°C) at room temperature and the extracts were evaporated to yield
the aziridinone (63) (46 mg, 97~), m.p. 29-3loC (lit.,49 32-33°C)
\
(Found; M+ 189.1160. Calc. for CI2H1SNO: M, 189.1154); vmax(CHCl3)1 850 cm-I;
a(CDC13 at DoC) 1.36 (9H, s, But), 3.87 (lH, s , CH), and 7.34 (SH, 5, Ph).
a.-ChZoro-N-t-butyZphcmyZacetamide (94) from N-t-ButyZ-3-phenyZ-
aziridinone (63). - A solution of the azt r+dtnone (63) (22 mg, 0.12 nunol)
in methylene chloride (1 m1) containing tetrabutylammonium chloride
(65 mg3 0.23 mmol) was stirred at room temperature overnight. Methylene
chloride (5 ml) was added and the solution was washed with water (1 ml),
dried, and evaporated. The residue was chromatographed on a silica
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plate [ethyl acetate-light petroleum (1:4)] to yield the amide (94)
(Rf 0.42) (14 mg, 53%) which crystallised from ethyl acetate-light
tpetroleum, 8(COC13) 1.37 (9H, s , Bu), 5.25 (lH, s, CH), 6.52 (lH, s, NH),
and 7.25-7.50 (SH, m, Ph).
N-t-Butyl-(3,3-dimethylbutano)hydroxamia Aaid (101). - A solution
of N-t-buty1hydroxy1amine (445 mg, 5 mmo1) in dry methylene chloride
(5 m1) containing triethylamine (0.8 m1, 5.8 mrno1) was cooled to DoC
and trimethylchlorosilane (0.7 ml, 5.5 rnmol) added. The mixture was
stirred for 15 min, cooled to -70°C and treated with triethylamine
(0.8 ml, 5.8 mmol) followed, dropwise over 30 min, by a solution of
3,3-dimethylbutanoy1 chloride (0.76 m1, 5.5 mmo1) in dry methylene
chloride (5 ml). The mixture was allowed to attain room temperature,
5% hydrochloric acid (5 ml) was added and the two layers separated.
The organic layer was washed with 5% hydrochloric acid (5 ml) and
water (5 ml), dried, and evaporated to give an oil which partially
crystallised from ethyl acetate. The product was filtered off and
washed with light petroleum (40-600e). The filtrate was extracted
with sodium hydroxide solution and the combined extracts were acidified
and extracted with light petroleum (40-60°C). These organic extracts
were dried and evaporated to give a second crop. The combined crops
were recrystallised from ethyl acetate to give the hydroxamia aaid (101)
(396 mg, 42%) as plates, m.p. lOO-101°C (Found: e, 64.07; H, 11.41;
+N, 7.47; M, 187.1570. CloH2lN02 requires c, 64.13; Ht 11.30; N, 7.48%;
M, 187.1572); vmax(CHC13) 3 540,3 220,1 645, and 1 615 cm-l;
o(CDC13) 1.00 (9H, s , CHBut), 1.41 (9H, s , NBut), 2.35 (2H, s , CH2),
and 7.48 (lH, br s, exchangeable with O2°, OH).
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Attempted Preparations of 1,3-Di-t-butylaziridin-2-one (99)
f!'Om N-t-ButyL-(3,3-dimethylbutanoJhydroxamia acid (101). - (a) With
triethylamine. A sol ution of the hydroxami c aci d (101) (47 mg, 0.25 mmo 1)
in dry methylene chloride (2 ml) containing triethylamine (77 ul,
0.55 mmel) was cooled to -70 C and trifluoromethanesulphonic anhydride
(50 ul, 0.3 mmol) added. The i.r. spectrum of the reaction mixture
showed no characteristic aziridinone carbonyl absorption. After
attaining room temperature the mixture was diluted with methylene
chloride, washed with water, dried and evaporated. The n.m.r. spectrum
of the residue was unclear.
(b) With 1,5-diazabicycu,[4.3.01non-5-ene (DBN). The procedure
was as above using DBN in place of triethylamine. The i .r. spectrum
of the reaction mixture showed no aziridinone carbonyl absorption and
the n.m.r. spectrum of the residue after work-up was unclear.
(c) With lithium diisop!'Opy~de. A solution of the hydroxamic
acid (101) (20 mg~ 0.11 mmol) in dry methylene chloride (1 ml)
containing triethylamine [170 ul (10% solution in methylene chloride),
0.12 mmel] was cooled to -70°C. Trifluoromethanesu1phonic anhydride
(20 ul, 0.12 mmol) was added, followed, after 5 min, by lithium
diisopropylamide (170 ul, 0.12 mmol) [prepared from diisopropylamine
(0.25 ml, 1.77 mmol) and butyl lithium (1.5M; 1.18 ml, 1 .77 mmol) in
-,
THF (1 ml)]. The i .r. spectrum of the reaction mixture showed no
\
aziridinone carbonyl absorption. The n.m.r. spectrum of the residue
after work-up suggested that the N-t-buty1 group had been lost.
14S-Amino-i'l-t-butoxy<.!arbonylnorcodeinone Ethylene Acetal (68)
The ethyl ene acetal (56) (134 mg " 0.25 nmo 1) was di sso 1ved in anhydrous
ethanol (5 m1), sodium ethoxide solution added (2 m1, 4 mol equiv.)
[from sodium (113 mg, 4.9 mmo1) in anhydrous ethanol (10 m1)] and the
solution was stirred for 0.5 h at room temperature. Water was then
added, the ethanol was evaporated and the aqueous residue extracted
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with chloroform (4 x 5 ml). The combined extracts were dried and
evaporated to yield the amine (68) which crystallised from ethyl
acetate as granules, (44 mg, 44%), m.p. 231-232°C (Found: C, 64.94;
H, 6.80; N, 5.98; M+, 442.2079. C24H30N206 requires C, 65.14; H, 6.83;
N, 6.33%; M, 442.2104); vmax(CHC13} 3 390,3 320, and 1 685 cm-I;
8(COC13) 1.45 (9H, s, But), 1.85 (2H, br s, exchangeable with 020, NH2),
3.86 (3H, s, OMe), 3.90-4.30 (4H, m, OCH2CH20), 4.53 (lH, br s, 5-H),
5.69 (lH, d, Js-H 9 Hz, 7-H), 5.92 (lH, d, J7-H 9 Hz, a-H), 6.53 (lH,
d, J2-H 8 Hz, 1-H), and 6.70 (lH, d, J1-H a Hz, 2-H).
14S-Aaetylamino-N-t-butoxyaarbonylnoraodeinone Ethylene Aaetal
(102). - The amine (68) (45 mg, 0.1 mmo1) was dissolved in pyridine
(2 m1) and acetic anhydride (2 drops) added. The solution was stirred
at room temperature for 1 h and then the solvent was evaporated.
The residual pyridine was removed by azeotroping with toluene (4 x)
to give the amide (102) which crystallised as the hydrate (30 mg, 59%),
m.p. 196-197°C (Found: C, 62.13; H, 7.03; N, 5.39;[M]+{-H20}, 484.2182.
C26H32N207.H20 requires C, 62.13; H, 6.82; N, 5.58%; [M] {-H20}, 484.2209);
vmax(CHC13) 3 635, 3 440,3 380 (sh), and 1 685 em-I; 5(COC13) 1.44
(9H, s, But), 1.90 (3H, s, CH3), 3.85 (3H, s, OMe), 3.90-4.30 (4H, m,
OCH2CH20), 4.51 (lH, br s , 9-H), 5.46 (lH, br s , 5-H), 5.67 (lH, d ,
JS-H 10 Hz, 7-H), 5.85 (lH, br s, exchangeable with 020, NH), 6.30 (lH,
d, J7-H 10 Hz, 8-H), 6.54 (lH, d, J2-H 8 Hz, 1-H), and 6.70 (lH, d, J1-H
8 Hz, 2-H).
l4B~minono~odeinone DihydroahlorideI7 (103). - The amine (68)
(20 mg, 0.045 mmo1) was dissolved in 3% anhydrous methanol;c hydrogen
chloride (1 ml) and the solution left overnight at room temperature.
Water (6 drops) was added and the solution was heated at 60°C for 0.5 h.
Evaporation of the solvent afforded the noreodeinone dihydrochloride (103)
(12 mg, 71%), m.p. > 320°C (Found: [M]+ ~2HC1} ,298.1309. Calc. for
CI7HlSN203.2HC1: [M] ~2HC1}, 298.1317); v (KBr) 2 930,2 810,2 500 (sh),max
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and 1 690 cm-I; o(020~ internal reference t-BuOH) 3.82 (3H, s, OMe),
5.17 (lH, s, 5-H), 6.27 (lH, d, J2_H 10 Hz, l-H), 6.92 (2H, s, 7-H and
8-H) and 7.10 (lH, d, J1-H 10 Hz, 2-H),
14S-Metmxycarbonylmethoxyaminocodeinone Ethylene Acetal (111). -
The crude cycloadduct (59) (106 mg, 0.25 mmo1) in methylene chloride
(1 ml) was treated with anhydrous hydrogen chloride in ethylene glycol
(1M; 1 ml). The solution was stirred at room temperature for 90 min
and then added to an excess of sodium methoxide solution (5 ml, 11 mol
equiv.) [from sodium (127 mg, 5.5 mmo1) in methanol (10 m1)]. The
solution was stirred for a further 30 min, diluted with water (5 m1),
and extracted with methylene chloride (6 x 5 ml). The combined extracts
were washed with brine (2 x 5 ml) and water (5 ml), dried, and evaporated.
The residue was chromatographed on a silica plate [methanol-chloroform
(1 ;9)] to yield the methy~ ester (111) (Rf 0.47) (33 mg, 29%) as an
oil (Found: M+, 444.1899; C23H2SN20, requires M, 444.1896); vrnax(CHC13)
3 260 and 1 750 cm'-l; 0 (CDC13) 2.33 (3H, s, NMe), 3.77 (3H, s, COOMe),
3.92 (3H, s , 3-OMe), 3.95-4.15 (4H, m, OCH2CH20), 4.14 and 4.44 (2H, d , d,
J 16 Hz, CH2CO), 4.77 (lH, s, 5-H), 5.70 (2H, s, 7-H and 8-H), 6.54
(lH, d, J2-H 8 Hz, 1-H), 6.70 (lH, d, J1-H 8 Hz, 2-H), and 7.88 (lH,
br s, exchangeable with 020, NH).
o.-ChZoro-N-t-rutyZaaetohydroxamia Acid (113). - To a stirred
solution of N-t-butylamine (890 mg, 10 mmo1) in methylene chloride (10 m1)
was added triethylamine (1.6 ml, 11 mmo1) and trimethy1ch10rosi1ane (1.4 m1,
11 mmo1). The mixture was stirred for 10 min and then treated with
triethylamine (1.6 nl, 11 nmo1) followed, dropwise, by a solution of
chloroacetyl chloride (0.88 m1, 11 mrno1) in methylene chloride (5 ml).
Stirring was continued for 10 min and then the mixture was washed with
5% hydrochloric acid (2 x 25 ml) and water (25 m1), dried and evaporated.
The product was purified on a chromatotron (2 mm plate). Elution with
ethyl acetate-light petroleum (3:1) afforded the hydroxamia acid (113)
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which crystallised slowly from ether-light petroleum (40-60°C) (438 mg,
27%) as cuboids, m.p. 78-80°C (Found: C, 43.73; H, 7.59; Cl, 21.44;
N, 8.53; M+, 167.0527,165.0566. C6HI2C1N02requires C, 43.50; H, 7.30;
Cl, 21.43; N, 8.46%; M, 167.0527, 165.0557); vmax(CC14) 3 200 and
1 645 cm-I; o(COC13) 1.42 (9H, s, But), 4.37 (2H, s, CH2), and 8.47 (lH,
br s, exchangeable with 020, OH).
N-(MethoxycarbonyLmethoxy) -t-butyLamine HydroahLoride (114a). - To
a solution of the hydroxamic acid (113) (50 mg, 0.3 mmo1) in methanol
(1 ml) was added sodium methoxide solution (0.56 m1, 1.1 mol equiv.)
[from sodium (135 mg, 5.9 I11l101)in methanol (10 m1)]. The solution was
stirred at room temperature for 2 h, acidified with 5% hydrochloric
acid and evaporated to dryness. The residue was extracted with methylene
chloride and the inorganic material filtered off and washed with
methylene chloride (twice). The filtrate was evaporated to yield the
hydroxyl-amine hydrochl-oride (114a) which crystallised from ethyl acetate
as cuboids (37 mg, 62%), m.p. 120-122°C (decomp.) (Found: C, 42.30;
H , 7.96; Cl, 18.31; N, 6.92; [M}+ {-HCn, 161.1048. C7H1SN03.HC1 requires
C, 42.52; H, 8.16; Cl, 17.96; N, 7.09%; [M] {-Hel}, 161.1052); vmax(CHC13)
2680,2600,2475, and 1760; o(CDC13) 1.50 (9H, s , But), 3.85 (3H, s ,
OMe), and 4.97 (2H, s, CH2).
N-(Ethoxyaarbonyl-methoxy) -t-butyZamine HydrochLoride (114b). - To
a solution of the hydroxamic acid (1·13) (50 mg, 0.3 mmo1) in ethanol (1 m1)
was added sodium ethoxide solution (0.86 m1, 1.1 mol equiv.) [from
sodium (89 mg, 3.9 mmol) in ethanol (10 ml)]. The solution was stirred
at room temperature for 1 h, acidified with 5% hydrochloric acid and
evaporated to dryness. The residue was extracted with methylene chloride
and the inorganic material filtered off and washed with methylene chloride
(twice). The filtrate was evaporated to yield the hydroxyLamine hydro-
chZoride (114b) which crystallised from ethyl acetate (46 mg, 72%),
m.p. 112-114°C (Found:[MY {-HC1}, 175.1197. CSH17N03.HC1 requires
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[M] ~HC1}~ 175.1208); vmax(CHC13) 2 680, 2 600, 2 460, and 1 755 cm-I;
to(CDC13) 1.30 (3H, t, JCH2 7 Hz, CH2CH3), 1.50 (9H, s~ Bu ),4.30
(2H, q, JCH 7 Hz, CH2CH3), 4.94 (2H, s, CH2CO), and 9.55 (2H, br s,3
. +exchangeable wlth 020, NH2).
2,2-Diethoxyacety~-1-adamantyZamine (116). - 1-Aminoadamantane
(2.65 g~ 17.5 mmo1), ethyl diethoxyacetate81 (3.39 g, 19.3 mmo1) in
sodium ethoxide solution (1.10 ml, 0.1 mol equiv.) [from sodium
(182 mg, 7.9 mmol) in dry ethanol (5 ml )l were heated together in a
distillation apparatus. When all the ethanol had distilled off (aa.
30 min) the residual liquid was diluted with ether (100 ml) and washed
with 5% aqueous oxalic acid (2 x 50 m1) and water (50 ml). The ethereal
solution was dried and evaporated to give a brown oil which was
distilled (Kugelrohr) (air bath temp. 195-205°C,0.2mbarHg) to yield
the adamantylamide (116) (3.56 g, 72%) as a pale yellow oil (Found:
M+, 281.1988. CI6H27N03 requires M, 281.1991); vmax(film) 3 410 and
1690 cm-l; o(COC13) 1.18 (6H, t, JCH2 7 Hz, CHss), 1.63 (6H, br s,
3xCHCH2CH), 1.97 (9H, br s , adamantyl CHs and remaining CH2s), 3.59
and 3.61 (4H, q,q, JCH3 7 Hz, 2xCH2CH3), 4.60 [lH, s , CH(OEt)z], and
6.25 (lH, br s, exchangeable with D20, NH).
A~ternative Preparation of a-ChZoro-N-t-butyZphenylacetamide (94)
from N-t-BUtyZhydroxyZamine. - To a solution of N-t-buty1hydroxylamine
(134 mg, 1.5 111110}.\ in dry benzene (3 m1) was added dry pyridine (0.29 ml,
3.6 mmol) and phenyl acetyl chloride (0.44 m1, 3.3 mmo1). The mixture
was heated under reflux for 3 h, cooled, diluted with benzene (7 m1),
and washed wi th 5% hydrochloric acid (2 x 5 m1), 5% sodium hydroxide
solution (2x5 ml), and water (5 ml). The dried benzene solution was
evaporated to give an oily solid. The amide (94) was sublimed from this
residue (bath temp. 110-120°C, aa. 15 mm Hg) and recrystallised from
ethyl acetate-light petroleum (114 mg, 34%), mixed m.p. (with authentic
amide) 131-132°C; o(COC13) 1.37 (9H, s, But), 5.26 (lH, s, CH), 6.50
(lH, br s, NH), and 7.25-7.50 (5H, m, Ph).
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